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ABSTRACT
THE EFFECT OF EARLY NURSING INTERVENTION 
ON CHEMOTHERAPY-INDUCED FATIGUE
By
Jennifer A. Shane
Chemotherapy-induced fatigue is a common side effect for cancer patients. This 
experimental study attempted to identify the effects of an early nursing intervention 
designed to facilitate adaptation to chemotherapy-induced fetigue. Roy’s Adaptation 
Model was the conceptual framework. A convenience sample (n=49) was randomly 
assigned to experimental (n= 16) and control (n=19) groups. Each group completed the 
Piper Fatigue Scale (PFS) during cycle one of chemotherapy. The control group received 
the standard teaching regarding 6tigue. The experimental group received additional 
instruction about fatigue. Both groups completed the PFS again during the third 
chemotherapy cycle (2-3 months later). No significant differences between the two 
groups were found. Additional analysis found significant differences between pretest and 
posttest for women (p=.036) but not for men (p=.233) and for the younger group 
(p=.003) but not the older group (p=.288). Chemotherapy-induced fetigue is a complex 
phenomenon requiring continued exploration of causes and treatments.
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CHAPTER 1 
INTRODUCTION
Chemotherapy-induced fatigue is a common side effect that often has harsh 
consequences on the cancer patient's quality of life. When the diagnosis of cancer is given, 
many are able to reach deep within themselves and find the strength and determination to 
fight. For most, they anticipate the side effects o f treatment and change in lifestyle that 
occur in the fight against cancer. What is being observed clinically is that many do not 
expect the severity and chronicity of fetigue that usually accompanies chemotherapy.
Nursing is defined as the "diagnosis and treatment of human responses to actual 
or potential health problems" (American Nurses Association [ANA], 1980). A primary 
concern for oncology nurses is to assist patients to cope with side effects associated with 
treatment. As traditional medical management has had little impact on chemotherapy- 
induced fetigue (Rhodes & Watson, 1987), nurses are often the patient care providers that 
recognize and try to influence chemotherapy-induced fetigue (Potempa, 1989).
Fatigue is a universal symptom without a universal definition (Pickard-HoUey,
1991; Nail & King, 1987; Jensen & Given, 1991; Rieger, 1988; Aistars, 1987; Piper,
Lindsey & Dodd, 1987). The variety of disciplines that examine fetigue fi'om their various
perspectives have led to many definitions o f fetigue (Pickard-Holley, 1991 ; Piper et al.,
1989; Nail & King, 1987; Jensen & Given, 1991; Aistars, 1987; Piper, Lindsey & Dodd,
1987; Piper, 1989; Nail, 1990). Piper et al. (1989)
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have defined fetigue as a "subjective feeling of tiredness that is influenced by circadian 
rhythm; it can vary in unpleasantness, duration, and intensity. When acute, fetigue serves 
a protective fimction; when it is excessive or chronic, its fimction is unknown" (p.200). 
Nail and King (1987) define fetigue as "a human response to the experience o f having 
cancer and to undergoing treatment for cancer. Fatigue is a self-recognized phenomenon 
involving how the individual feels and how this feeling influences the activities in which 
one chooses to engage" (p.257). These definitions present the subjective view or "human 
response" to fatigue.
In 1995, the pharmaceutical company Ortho Biotech agreed to fimd a large grant 
to the Oncology Nursing Society and FoundatioiL This project, called the Fatigue 
Initiative through Research and Education (FIRE), sponsored grants, studies, and 
educational programs designed to enlighten patients, consumers, and healthcare providers 
to the scope of the fetigue problem. Together with the recent acceptance of chronic 
fetigue as a nursing diagnosis by the North American Nursing Diagnosis Association 
(NANDA, 1990) and the definitions of fatigue, nurses are given formal backing for the 
study of fetigue and confirm the professional responsibility of nurses to adequately 
diagnose and treat chronic fatigue (Potempa, 1989; Skalla & Laçasse, 1992).
Although research documents that fetigue is a common side effect of 
chemotherapy (Pickard-Holley, 1991; Rhodes, Watson, & Hanson, 1988; Meyerowitz, 
Sparks & Spears, 1979; McCorkle & Young, 1978; Love, Leventhal, Easterling, & 
Nerenz, 1989; Benedict, 1989; Bleschet al., 1991; Meyerowitz, Watkins, & Sparks,
1983), a review of the literature reveals few studies focused on nursing interventions 
designed to prevent or alleviate fatigue (MacVicar, Winningham, & Nickel, 1989;
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Cimprich, 1993; Johnson, Nail, Lauver, King & Keys, 1988; Mock et al., 1994; MacVicar 
& Winningham, 1986). These studies looked at improving functional capacity via aerobic 
exercise in cancer patients (MacVicar & Winningham, 1986; MacVicar, Winningham & 
Nickel, 1989), restoring attentional fetigue by engaging in activities that promote 
fescination (Cimprich, 1993), and decreasing the perception of fetigue by providing 
information encompassing the radiation experience including treatment planning for 
expected experiences after radiation is completed (Johnson et al., 1988).
Common side effects are often considered by patients as reasons to quit 
chemotherapy. Love, Leventhal, Easterling and Nerenz (1989) identified that nausea, hair 
loss, and tiredness were each experienced by more than 80% of patients and that almost 
half (46%) had thought of quitting therapy by the sixth cycle of treatment. The 
researchers summarized that side effects may be better controlled if techniques to help 
manage them were identified, especially fi)r tiredness and other more vague or hard to 
define side effects (Love et al., 1989). A descriptive study by Nail, Jones, Greene, 
Schipper, and Jensen (1991) was designed to increase the knowledge base of oncology 
professionals regarding patient experiences in dealing with chemotherapy. The study 
revealed that fetigue was the most common side effect, experienced by 81% of the 
subjects.
Patients have identified self-care activities that relieve some of these side effects 
and enhance acceptance of chemotherapy. Rhodes, Watson, and Hanson (1988) described 
the relationship between patients' self-reported symptoms and their self-care activities 
while receiving chemotherapy. Subjects reported that self-care activities were most often 
inhibited by the symptoms of tiredness and weakness. They also reported that the
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expenditure of energy was decreased by planning and scheduling activities (including 
work), decreasing nonessential activities, and increasing their dependence on others 
(Rhodes, Watson, & Hanson, 1988). These identified self-care interventions can be 
incorporated into a teaching plan designed by nurses. The information can then be given 
to patients prior to startup chemotherapy in hopes of 6cilitating adaptation to 
chemotherapy-induced fetigue.
Providing patients with information regarding potential side effects may help 
them establish self-care measures prior to the onset of the expected side effects. Dodd 
(1983) designed a study "to determine 1) whether patients practice self-care; 2) whether 
patients instructed in side-effect management techniques (SEMT) will adopt these 
techniques; and 3) whether information on SEMT, given alone or in combination with 
other (e.g., drug) information, elicits differential self-care behaviors" (p. 63). The study 
revealed that the patients who received SEMT information performed more self-care 
behaviors than the patients who received none and that the SEMT groups initiated these 
behaviors earlier, before their side-effects became severe. This study points to many 
advantages if patients are provided with SEMTs.
Roy's Adaptation Model (RAM) will be used as the conceptual framework for 
this study. Many of the articles reviewed for this study have used Orem's self-care 
theoretical framework as their foundation and the use of the term "self-care" has been 
preserved and incorporated into the paragraphs written by this author. The RAM was 
chosen for this study because its focus is on adaptation of the patient to a particular 
phenomenon. Through research directed by the Roy Adaptation Model nurses can
improve their understanding of the way patients adapt to constantly changing 
environmental stimuli.
Roy’s model states that "persons or adaptive systems interact with the 
environment and move toward the goal of adaptation and health" (Roy, 1984). According 
to Roy, the goal of nursing is the promotion of adaptation, thereby fostering a person's 
health, quality o f life and dying with dignity. A fetigue framework developed by Piper, 
Lindsey, and Dodd (1987) is a descriptive model that synthesizes the fatigue literature to 
generate nursing theory about fetigue in cancer patients. The fi’amework directs the nurse 
to assess possible causes of fetigue in specific patient situations and to select appropriate 
nursing interventions to test. Roy’s adaptation model. Piper’s fetigue framework, and a 
teaching tool designed to educate patients about fatigue can be brought together to 
promote adaptation by facilitating acquired coping mechanisms.
Problem
The studies presented in the introduction document the prevalence of fetigue as a 
reported side effect and its impact on quality o f life. These studies along with nursing's 
definition of fetigue, NANDA's acceptance of chronic fetigue as a nursing diagnosis, and 
FIRE, lay the foundation for the study presented here. The question of interest is what are 
the effects of early nursing interventions designed to promote or fecilitate adaptation to 
chemotherapy-induced fetigue? The purpose o f this study is to examine interventions that 
promote adaptation to fetigue by randomly assigning first-time chemotherapy patients to 
two groups: (a) adaptation-promoting early nursing intervention group or (b) control 
group, which receives the regular education given to chemotherapy patients.
CHAPTER 2
REVIEW OF THE LITERATURE AND CONCEPTUAL FRAMEWORK 
Literature Review
Oncology nursing has become a specialty over the past 15-20 years. Along with 
this trend there has been a growing interest in the phenomenon of fatigue. The increase in 
the number of studies in recent years on fetigue in the cancer patient shows that oncology 
nurses are dedicated to the scientific study of the fetigue phenomenon. Most authors of 
fatigue research agree that oncology nurses need to continue to examine fetigue in order 
to intervene successfully.
A review of the literature was conducted regarding fetigue in the cancer patient 
and the 15 articles found were divided into 4 topic areas: (a) fetigue as a common side 
effect of chemotherapy, (b) patients' methods to counteract fetigue, (c) nursing 
interventions for fatigue and, (d) fetigue interventions identified by other professionals.
Fatigue as a common side effect of chemotherapv. Research has suggested that 
fetigue is a common side effect of patients receiving chemotherapy. A study by 
Meyerowitz et al. (1979) describing the psychosocial effects of adjuvant chemotherapy 
(chemotherapy used in addition to the primary surgical treatment) in stage II breast cancer 
patients revealed fetigue as the most frequent symptom with an incidence of 96% (48 of 
50 patients). An exploratory study by Blesch et al. (1991) designed to examine and 
describe "the perception and manifestations of fetigue and its physiological, biochemical,
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and behavioral correlates" (p. 81) found that 99% (75 of 76 subjects) experienced some 
level of fotigue. Another study by Meyerowitz et al. (1983) reported on the quality of life 
for breast cancer patients receiving adjuvant chemotherapy. Fatigue was identified as the 
number one disruptive symptom with 96% of the subjects reporting fotigue. In McCorkle 
and Young's (1978) study designed to develop a system distress scale, fatigue was 
identified as the fifth (out of 10) most distressful symptom as perceived by the cancer 
patient. Weakness/fetigue was reported to be one of the sources of greatest suffering by 
patients with lung cancer (Benedict, 1989). Although the greatest limitation of these 
studies is their small sample sizes and convenience sampling method, they do indicate that 
fotigue is an all too common side effect of cancer treatment that has an impact on the 
patient's quality of life.
A study by Irvine, Vincent, Graydon, Bubela, and Thompson (1994) expanded 
the research on the prevalence of fatigue by comparing the fatigue experienced by 
chemotherapy and radiotherapy patients with the fetigue experienced by apparently 
healthy individuals. They found that among their sample there was no difference in the 
mean level of fetigue between the cancer patients and the control group before the start of 
treatment. But by the end of the 5-6 week course of radiotherapy or 14 days after 
chemotherapy the cancer patients had experienced a significant increase in their levels of 
fetigue.
Patients' methods to counteract fatigue. Patients are often a great source of 
information for nurses. Just asking the patient who has experienced a particular 
phenomenon of interest can provide a nurse with a wealth of information to use in future 
nursing interventions. In a study conducted by Rhodes et al. (1988), patients were able to
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identify three self-care activities that assisted them to adjust and cope with the symptom of 
tiredness/weakness. The purpose of the study was to "examine the relationship between 
self reported symptoms and self-care agency perceived by patients receiving antineoplastic 
chemotherapy " (p. 186). Patients (n =20) receiving an average of six cycles of 
chemotherapy were interviewed by telephone. They reported that the symptoms that most 
interfered with self-care activities were tiredness and weakness. The self-care activities 
reported most firequently to help with these symptoms included planning/scheduling 
activities and work, decreasing nonessential activities and increasing dependence on others 
for home management. This study is limited by its small sample size and convenience 
sampling but it does imply that "patients adjust their activities to cope with the symptom 
of fatigue" (p. 193). Nurses can use the information from this study to take a proactive 
stance. By providing the chemotherapy patient with the identified self-care activities prior 
to the onset of tiredness and weakness, the patient could adapt to the side effects as they 
develop thereby decreasing their severity. This is suggested by the authors as an avenue 
for future research and is the focus of the study presented in this paper.
Nail et al. (1991) designed a descriptive study to increase professionals' 
knowledge base of patients' experiences in dealing with chemotherapy. A convenience 
sanqjle (n=49) was used. It consisted of predominantly white (98%), females (61%), who 
were married (75.5%) and middle-aged (mean age = 54.9 yrs). A variety of diagnoses and 
treatment regimens were included. A self-care diary was developed by the authors for this 
study. The self-care diary included a list of 18 possible side effects and provided space for 
other experiences perceived as side effects of treatment (the list was derived from the 
literature by the authors). Patients were then asked to rate the severity of each side effect
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experienced and record the self-care activity used at two and five days post treatment. 
Fatigue was the most firequently reported side effect (81%). Patients identified that taking 
naps, going to bed earlier, sleeping later and keeping busy to keep their mind off 6tigue 
were self-care activities they employed against 6tigue. Limitations include a small 
convenience sample (n=49), heterogeneous population including different diagnoses and 
treatments, patients who had had previous treatments and therefore possibly altered 
perceptions, and combinations of self-care activities used by patients. Despite these 
limitations, the authors concluded that the high incidence of 6tigue reported challenges 
nurses to prepare patients for the likelihood of chemotherapy-induced fatigue.
Nursing interventions for fatigue. A variety of nursing interventions have been 
used to try to decrease or alleviate fetigue associated with cancer treatment but few have 
been tested empirically (Nail & King, 1987). One study by MacVicar, Winningham and 
Nickel (1989) tested the effects of a 10-week aerobic exercise training program on the 
fimctional capacity of women (n=45) undergoing chemotherapy for stage II breast cancer. 
Functional capacity was measured as the volume of inspired oxygen in liters per minute. 
The results showed that the functional capacity of the experimental group improved 
significantly from pretest to posttest but no significant pre- to posttest changes were noted 
for the control or placebo groups. Limitations include an undefined relationship between 
functional capacity (as defined in this study) and self-care activities, and a small sample 
size. Although self-care activities were not measured, the increases in functional capacity 
could improve the individual's ability to perform ADLs. The data suggest that nursing 
should implement interventions designed to improve functional capacity.
Cimprich (1993) studied 32 women during the three month period following 
surgery for localized breast cancer. The study tested the effects of an intervention 
designed to minimize or prevent attentional 6tigue. The intervention consisted of 
engaging in regular activities that promote 6scination. Using subjective and objective 
measures, attentional capacity was assessed at approximately 3,18, 60 and 90 days after 
surgery. While the nonintervention group showed a pattern of inconsistent performance 
over time, the intervention group showed significant improvement in attentional capacity. 
This study had a number of limitations including questionable validity and reliability o f the 
instrument used to measure attention (the instrument was created for this study) and the 
inability of the researchers to ensure that the specific restorative intervention was the 
reason for the increase in attentional capacity. The possibility exists that any intervention 
that facilitated the recovery process could have a beneficial effect on attentional capacity.
Johnson, Nail, Lauver, King and Keys (1988) examined the effect of an 
informational intervention on the functional status o f radiation therapy patients, 
specifically the ability to cope with side effects and mood disturbances. Patients in the 
control group (n=42) received the usual information provided to radiation patients. The 
experimental group (n=42) received, in addition to the usual information, four 
informational messages describing the experience o f  treatment planning, experience of 
receiving radiation, usual side effects (including their onset, characteristics, and activities 
to decrease their severity), and the usual experiences once radiation is completed. These 
messages were tape recorded and given to the patients at various times throughout the 
course of treatment. As measured by the Sickness Impact Profile, the experimental group 
reported less disruption in usual activities during and following radiation. The amount of
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emotional disturbance, as measured by the Profile of Mood States was low for both the 
experimental and control groups and did not differ significantly. The study supports prior 
research findings that preparatory infisrmation can lessen the disruption in usual activities 
of patients coping with stressful health care experiences. This could be a significant factor 
in cancer patients' quality o f life. This was a well designed study as it built on previous 
research and the authors tried to address the limitations of the previous studies. The 
researchers (a) randomly assigned patients to the experimental and control groups, (b) 
restricted the sample to an early stage disease, (c) followed patients for three months after 
the study, (d) extended the evaluation of effectiveness by measuring disruption of activities 
as well as emotional disturbance, and (e) used appropriate interventions that have been 
found to facilitate coping in other health care experiences.
Dodd (1983) examined whether chemotherapy patients instructed in side-effect 
management techniques would assiune these techniques. Her results were significant in 
that the patients (n=24) who received information on side-effect management techniques 
showed no significant relationship between severity of side-effects and initiation of self- 
care in post-intervention interview (r = .19, p = .36). That is, patients did not wait until 
the side effects became severe before initiating side-effect management techniques. The 
group (n = 24) that did not receive the information continued to show a significant 
relationship between the severity of side-effects and initiation of self-care (r = .41, p =
.04) thereby waiting until side-effects became severe before initiating management 
techniques. Limitations of this study include a heterogeneous sample (small sample size, 
multiple diagnostic categories and chemotherapy protocols) and that patients were asked 
to recall the self-care behaviors performed fi’om memory, decreasing the reliability.
II
Dodd's findings can be applied to chemotherapy-induced fatigue. If patients can be given 
management techniques to help them initiate self-care behaviors prior to the onset of 
6tigue then adaptation may be enhanced.
Fatigue interventions identified bv other prnfessinnals. Gerber et al. (1987) 
studied a patient education program designed to teach energy conservation behaviors to 
patients with rheumatoid arthritis. Patients were randomly assigned to either the 
experimental workbook group (n = 16) or the standard control group (n = 9). 
Preintervention and postintervention measurements of disease activity, disability and 
psychosocial adjustment to illness were taken. Although no statistical differences were 
found between the two groups, two measures approached significance. The first was the 
amount of time spent being physically active. Physical activity increased in 50% of the 
experimental group but only in 11% of the control group (p = .10). The second measure 
to approach significance was a better balance between rest and activity achieved by 50% 
of the experimental group but only 22% of the control group (p = .07). This indicates that 
the experimental group interrupted their physical activity with rest periods, a behavior 
identified as important in the workbook. Due to the small sample size, the authors were 
not surprised that statistically significant differences were not identified. One of the main 
goals of the study was to learn whether the workbook produced the desired behavior.
Others have advocated a variety of nursing interventions to help decrease the 
fatigue during cancer treatment. These include conservation of energy, nutritional 
management, stress management and management of contributing fectors (Rieger, 1988), 
as well as patient counseling and promotion of adaptation to fatigue because of its often 
chronic nature in the cancer patient (Aistars, 1987).
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In summary, a review of the literature has revealed that the nursing 
profession needs to continue to explore the phenomenon of fetigue through research. 
Although many articles have been written about fetigue in the cancer patient, few have 
empirically tested nursing interventions designed to combat fetigue. Because in many 
cases medical management does not alleviate fetigue, nursing interventions may be the 
only source of hope to improve cancer patients' quality of life. Studies designed to test 
nursing interventions often had small, heterogeneous, convenience samples that reduced 
the generalizability of the findings. Although these studies add valuable information to the 
body of knowledge regarding fetigue, research in this area needs to continue.
Conceptual Framework
Roy’s Adaptation Model. The Roy Adaptation Model (Roy & Andrews, 1991) 
provided the firamework for this study. Roy’s conceptual model of nursing supplies nurses 
with a "road map" allowing them to focus on a particular phenomenon, implement 
interventions and predict possible outcomes. In this study, the phenomenon of fetigue will 
be assessed using the Roy Adaptation Model. A specific nursing intervention will be 
implemented at the control processes aspect of the model and the outcome of positive 
adaptation will be anticipated (see Figures 1 & 2). Roy's 1984 model o f the person as an 
adaptive system will be used to more clearly show where nursing will intervene. Roy’s 
1991 model of the person as an adaptive system is helpful in depicting the interrelatedness 
o f the four adaptive modes (Figure 3).
Roy defines the nursing’s goal as "promotion of adaptation in each of the four 
modes, thereby contributing to the person’s health, quality of life, and dying with dignity" 
(Roy & Andrews, 1991, p.20). The recipient of nursing care is an adaptive system. Roy
13
defines the person's adaptation level as "the changing point that represents the person's 
ability to respond positively in a situation" (Roy & Andrews, 1991, p.lO).
Input
ScunuU
Control
pmccMcs
''Coping 
m ediuisnu 
Regulator 
Cognator
Effectors
Physiological function 
’ Seu-concept 
Role functwn 
Interdependence,
Feedback
Output
Adaptive
and
"Ineffecine
lesponss
Figure 1. The person as an adaptive system.
Note. From Introduction to Nursing: An Adaptation Model f2nd Ed.1 ('p.30'1. 
by C. Roy, 1984, Englewood CüflÈ, NJ: Prentice HalL Copyright 1984 by 
Appleton & Lange. Reprinted by permission (see Appendix A).
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Figure 3. The person as an adaptive system.
Note. From The Rov Adaptation Model: The definitive statement ^p. 17). 
by C. Roy & H. A. Andrews, 1991, Norwalk: Appleton & Lange. Copyright 
1991 by Appleton & Lange. Reprinted by permission (see Appendix A).
There are three forms of input or stimuli that make up a person's adaptation 
level. These are termed focal, contextual, and residual stimuli. When describing the 
relevant stimuli that afTect a person's range of coping or adaptation level, the focal, 
contextual, and residual stimuli must be reviewed (Roy & Andrews, 1991). The focal 
stimulus is the most critical stimulus as it is the immediate threat to the person and is the 
cause for the adaptation response. For the purposes of this study, the focal stimuli are the 
disease process and subsequent chemotherapy. All other stimuli that may be influencing 
the current situation are called contextual stimuli. In this study, examples of this form of 
stimuli could include role changes secondary to treatment and disease, responsiveness of 
family and &iends, and the occurrence of a fomily milestone (such as the last child going 
off to college). The residual stimuli are any remaining stimuli that may be affecting the
adaptation level but either cannot or have not been identified and/or confirmed.
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The adaptation level and stimuli serve as input to the person as an adaptive 
system. The iiqiut is then processed through control mechanisms. The regulator and 
cognator subsystems are two internal control processes that the adaptive system uses to 
respond to changes in internal and external environmental stimuli. The regulator and 
cognator subsystems are viewed by Roy and Andrews (1991) as innate or acquired coping 
mechanisms. While innate coping mechanisms are genetically determined, the acquired 
coping mechanisms can be developed through processes such as learning. It is not 
possible to observe the functioning of the regulator and cognator subsystems, but the 
responses that are produced can be observed. These responses are manifested through 
coping behavior observed in four categories or adaptive modes that were developed by 
Roy and Andrews (1991) and that can be used as a framework for nursing assessment. 
These modes are the physiological, self-concept, role function, and interdependence mode.
The physiological mode "is associated with the way the person responds as a 
physical being to stimuli from the environment" (Roy & Andrews, 1991, p. 15). The 
activities o f the cells, tissues, organs and systems of the body make up the behaviors of 
this mode. The stimuli affecting the person will activate the coping mechanisms producing 
adaptive and/or ineffective behavior. In this mode "the coping mechanisms are those 
associated with physiological functioning and the responses produced are physiological 
behaviors" (Roy & Andrews, 1991, p.15). There are five needs associated with 
physiological integrity: oxygenation, nutrition, elimination, activity and rest, and 
protection. There are four complex processes associated with physiologic integrity: 
senses, fluids and electrolytes, neurological function, and endocrine function. These
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combine to form the nine components used as a basis for nursing assessment in the 
physiological mode.
The other three adaptive modes in Roy's model are psychosocial modes. The 
first of these is the self-concept mode. It includes the individual's psychological and 
spiritual aspects. Psychic integrity is the basic need underlying the self-concept mode and 
is defined by Roy as "the need to know who one is so that one can be or exist with a sense 
[of] unity" (Roy & Andrews, 1991, p. 16). The self-concept mode is viewed as having two 
components: "the physical self including body sensation and body image and the personal 
self comprised of self-consistency, self-ideal, and moral-ethical-spiritual self (Roy & 
Andrews, 1991, p. 16).
The second of these psychosocial modes is the role function mode. The roles a 
person occupies in society is the focus o f this mode. Roy defines a role as a "set of 
expectations about how a person occupying one position behaves toward a person 
occupying another position" (Roy & Andrews, 1991, p. 16). Social integrity is the basic 
need underlying this mode and is defined as "the need to know who one is in relation to 
others so that one can act" (Roy & Andrews, 1991, p. 16).
The final adaptive mode in Roy's model is the interdependence mode.
Affectional adequacy is defined as "the feeling of security in nurturing relationships" (Roy 
& Andrews, 1991, p. 17) and is the basic need of this mode. The interactions related to 
the giving and receiving of love, respect and value are the focus of this mode.
Though the four adaptive modes are often viewed separately for assessment 
purposes, nurses must remember that they are interrelated. This demonstrates the holistic 
and complex nature of the person. As shown in figure 3, the four modes are represented
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as overlapping circles with a central circle representing a person's coping mechanisms.
The behavioral responses manifested through the four adaptive modes "may be either 
adaptive and thus promoting the integrity and wholeness of the person (as depicted by the 
arrow remaining with [in] the adaptation circle) or ineffective and not contributing to the 
goals of the person (arrows extending beyond the adaptation circle)" (Roy & Andrews, 
1991, p.21).
Studies using Rov’s model. Roy’s Theory of Adaptation or Roy's Adaptation 
Model (RAM) has been the framework for numerous studies (Fawcett, 1989). Fawcett 
(1990) described an ongoing program of research (four studies in all) designed to develop 
and test nursing interventions derived from RAM. Roy’s conceptual model served as a 
blueprint for the design and conduct o f the studies. Support for the credibility o f Roy’s 
model was found in the first three studies (Fawcett & Tulman, 1990). However, 
hypotheses in the fourth study were based on a Roy Adaptation Model proposition that 
management of contextual stimuli promotes adaptation. Research findings did not support 
this proposition and therefore challenge the credibility of the RAM. The authors suggest 
that the study may not have thoroughly tested the proposition because the contextual 
stimuli, in the form of experimental and control treatments, did not differ substantially 
(Fawcett et al., 1993). Fawcett used the Roy Adaptation Model to guide future research 
studies and believed it to be a useful fi-amework, especially for content analysis (Reichert, 
Baron, & Fawcett, 1993; Fawcett, Tulman, & Spedden, 1994).
Varvarro (1991) applied RAM to women with coronary heart disease. Two key 
concepts from Roy's model, the focal and contextual stimuli as influencing adaptation and 
the four modes of adaptive response, were used to gather information regarding the life
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experience of women (n = 83) with coronary heart disease. Roy's model was used to 
assess the patient's adaptation or non-adaptation to stimuli in the four adaptive modes. 
Specific measurements under each o f the four modes were outlined and various scales 
were used to assess and obtain the measurements. The study reported that the women 
identified focal stimuli related to the physiological and role fimction modes as occurring 
most fi'equently. The physiological stimuli such as fetigue and loss of energy may have 
affected role fimction. The utility o f using a nursing theory as an organizing fi-amework to 
assess life experiences in women with coronary heart disease was demonstrated in the 
study. These studies show the utility of the RAM to various nursing specialties and to 
nursing as a profession.
Fatigue firamework. Piper, Lindsey and Dodd (1987) proposed a firamework for 
the conceptualization of fetigue that allows "multiple discipline perspectives, definitions, 
and theories to be analyzed" (p. 17). Their project was undertaken in part because of the 
numerous definitions of fatigue across disciplines and because so little is known about the 
varied mechanisms that produce fatigue. The fiumework can be used to help develop a 
nursing theory about fetigue with the goal being to "identify and predict which patients are 
at high risk for fetigue in order to test specific nursing interventions that prevent or 
ameliorate its occurrence" (Piper et al., 1987, p. 17). Figure 4 represents the Piper et al. 
(1987) fetigue fiumework for the conceptualization of fetigue in healthy and clinical 
populations. The center circle contains the manifestations of fiitigue, both subjective and 
objective, that have been reported. The mechanisms o f fatigue are situated around the 
circle and may or may not have an impact on an individual's fatigue symptoms. Although 
the actual mechanisms that produce fatigue are unknown, the fi-amework allows the nurse
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to begin an assessment and possibly intervene. The 6tigue framework he^s "round out" 
Roy's model by having synthesized the 6tigue literature and by generating a framework 
that allows the nurse to begin to "assess possible causes of fritigue in a specific patient 
situation to select an appropriate intervention to test" ( P ^  et aL, 1987, p.20).
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Figure 4. Fatigue fimnework.
Note. From ‘Tatigue mechanisms in cancer patients: Developing nursing 
theory” by B.F.Piper, A.M.Lindsey, & M.J.Dodd, 1987, Qncoloev Nursing 
Forum. 14. p. 19. Copyright 1987 by B. Piper (see Appendix A).
Need for Further Study
Further study of the 6tigue phenomenon in cancer patients is warranted to help 
inq)rove the quality of life in this patient population. Often patients do not expect the 
severity of fatigue experienced once chemotherapy has begun. They often lack 
appropriate measures/activities to help alleviate fetigue synçtoms or wait too long to
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implement them. Nurses have a responsibility to assist patients with fatigue symptoms. 
The high incidence of 6tigue and the lack of impact by medical management on fatigue 
open the door for the nursing profession to intervene. Empirical testing of specific nursing 
interventions needs to continue. The study presented in this paper strives to add to 
nursing's body of knowledge regarding fatigue and related nursing interventions.
Research Question
What are the effects of early nursing interventions designed to promote or 
facilitate adaptation to chemotherapy-induced fotigue?
Research Hvpothesis
The early nursing intervention group will subjectively adapt to the fatigue 
experience associated with chemotherapy more positively, as measured by scoring lower 
on the Piper Fatigue Scale (PFS) (Piper et al., 1989), than the control group.
Kev Terms
1. Early nursing intervention— A teaching intervention that is provided to the 
patient/femily prior to completion of the initial chemotherapy treatment thus enhancing the 
patient's acquired coping mechanisms and focilitating adaptation.
2. Fatigue— "a subjective feeling of tiredness that is influenced by circadian 
rhythm; it can vary in unpleasantness, duration and intensity. When acute, fatigue serves 
a protective fimction; when excessive or chronic, its fimction is unknown" (Piper et al., 
1989, p. 200), Fatigue is manifested as an effector state in Roy's model. Subjective 
fetigue will be measured by the Piper Fatigue Scale.
3. First-time chemotherapy patients— the recently diagnosed cancer patient 
(having been diagnosed with a new or recurrent cancer in the past one to three months)
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presenting to the outpatient chemotherapy clinic to receive a minimum of three cycles of 
chemotherapy. Patients will have received no prior medical treatment other than surgery 
for their disease (i.e., no immunotherapy or radiation).
Kev Concepts
1. Adaptation— a change in structure, function, or form that produces better 
adjustment of a person to his/her environment(Guralnik, 1980, p. 15), as measured by the 
PFS.
2. Acquired coping mechanisms— learned behaviors that 6cilitate adaptation. 
To be taught in the early nursing intervention.
CHAPTERS
METHODOLOGY
Design
The following experimental study examined the relationship of early nursing 
interventions (designed to promote adaptation to chemotherapy-induced fetigue) and 
chemotherapy patients' level of adaptation. A pretest posttest experimental design was 
chosen to strengthen the study results by achieving "greater confidence in the genuiness 
and interpretability of relationships" (Polit & Hungler, 1991, p. 152). A convenience 
sample was used and subjects were randomly assigned to the experimental and control 
groups. Manipulation occurred in the experimental group by the use o f nursing 
interventions designed to promote adaptation to chemotherapy-induced fatigue. Patients 
were given the pretest on the first day of their chemotherapy regimen. The control group 
received the regular nursing instructions (see Appendix B) that included a statement such 
as "You may experience fetigue due to your chemotherapy." The experimental group 
received verbal and written information on fatigue (see Appendices B & C). After two full 
cycles of chemotherapy (on the first day of the third treatment) all patients completed the 
posttest.
Potential threats to internal validity included history, testing, and mortality. The 
occurrence of external events during the two to three month time span between the pretest 
and posttest may have had an impact on how patients adapted to fatigue. Various pieces
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of literature, well-meaning friends and/or increased media attention could have affected 
patients in either group and therefore this threat was minimized. Testing was another 
potential threat to internal validity. The effect of taking the pretest may have influenced 
the patients' responses on the posttest. Because all of the patients completed the pretest 
and posttest, this threat should be equalized, if not eliminated. Loss of subjects in each 
group occurred for a variety o f reasons including death, discontinuation of the 
chemotherapy regimen, foilure to have the patient complete the posttest, and foilure o f the 
patient to complete more than 65% of the pre or posttest. This threat is a limitation of this 
study and is discussed further.
Threats to external validity included a decrease in the ability to generalize the 
study results and the potential for a Hawthorne effect. Although the results of this study 
can only be generalized back to the sample, the information obtained will add to the body 
of knowledge regarding fetigue. The Hawthorne effect could have affected both groups 
due to the extra attention received during the research process. Patients could perceive 
their fatigue as less severe and demonstrate this on the Piper Fatigue Scale. This threat 
should be equal in both groups as all patients received some form of educational material 
regarding side effects.
Sample
The subjects were chosen for study from the outpatient chemotherapy clinic of a 
250 bed acute care fecility. Approximately six months into data collection the doctors’ 
group which referred the majority of patients to the clinic moved their practice to a 
private ofSce. All patients were transferred to this new office and referrals from this office 
were placed on study in the same manner.
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Subjects were randomly assigned to the experimental and control groups. The 
first 25 numbers between 1 and 50 obtained firom a table of random numbers were 
designated the experimental group. All others were placed in the control group. The 
author then wrote out a master list with three columns that listed the patient number, 
assigned group, and place for the patient name. Names o f consecutive patients who met 
the criteria were placed on the list in order and thus assigned to groups. Each patient had 
a packet coded with their corresponding number. The packet included a fetigue pamphlet 
(Appendix C) (experimental group only), two Piper Fatigue Scales (Appendix D), a 
demographic sheet (Appendix E), and two consent forms (Appendix F) (one for the 
researcher and one for the patient). At the completion o f this study, the master list was 
destroyed via paper shredder.
Subjects eligible for study were recently diagnosed cancer patients (having been 
diagnosed with a new cancer or recurrent cancer in the past 1-3 months) who presented to 
the outpatient chemotherapy clinic (hospital based clinic or private office clinic) to receive 
a minimum of three cycles of chemotherapy. A cycle o f chemotherapy varies depending 
upon individual aspects of each patient, such as age, type of cancer, and medical history. 
Generally, a cycle of chemotherapy is three to four weeks in length. No limits on the type 
o f cancer, underlying conditions, or type of chemotherapy regimen were placed on 
subjects eligible for study as the nursing literature supports that fatigue is a universally 
recognized side effect of chemotherapy treatment. Patients had to be 18 years or older 
and be able to read and write English. Criteria making patients ineligible for study 
included patients having received chemotherapy or radiation therapy for their disease
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process in the past year and patients receiving other concurrent medical treatment such as 
radiation or unproven methods for their cancer (recent surgical procedures permitted).
The original sample o f 50 patients was reduced to 49 after one patient, having 
completed the pretest, was foimd to be receiving concurrent radiation therapy. The 
experimental group contained 24 subjects and the control group had 25 subjects. There 
were more females (61.2%) than males (38.8%) in the total sample. Ages ranged from 19 
to 83 years of age with a mean of 57.9 years. Of the original 49 subjects only 35 
completed both the pre and posttest and, therefore, the study. The 14 subjects were lost 
for the following reasons: (a) deceased, (b) taken off chemotherapy, (c) Mure to 
complete more than 64% of pre or posttest, or (d) M ure to conq)lete posttest. The final 
sample of 35 subjects ranged in age from 19 to 79 years with a mean of 56.8. There were 
12 men (34.3%) and 23 (65.7%) women. These data are summarized in Table 1.
Patients were receiving a variety of chemotherapy regimens for a variety of 
cancers (Table 2). Patients were not receiving concurrent radiation therapy or 
immunotherapy.
Most subjects in the original group (n = 49) lived in a house (87.8%) and no one 
resided in a nursing home. Subjects who lived alone accounted 20.8% of the sample. A 
little more than 60% of the sample had 1 or 2 persons living with them. No subjects had 
more than 6 persons living with them. Most subjects (89.3%) could rely on those who 
lived with them for support with everyday tasks such as housekeeping, errands, and meals. 
The remaining sample of 35 subjects also predominantly lived in a house (88.6%). Most 
patients had 1-2 persons living with them (64.7%). Among the persons living with the 
subjects, 88.2% could be relied on for some type of support (see Table 3).
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Table 1
Sample Characteristics
characteristics original (n=49) remaining (n= 35)
n % n %
Gender
Male 19 38.8 12 34.3
Female 30 61.2 23 65.7
Age (years)
19-40 8 16.3 7 20.1
41-50 7 14.3 4 11.6
51-60 8 16.3 6 17.3
61-70 16 32.7 12 34.4
71-83 10 20.4 6 17.3
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Table 2
Cancer Diagnoses of Sample
type of cancer original (n=49) remaining (n=35)
n % n %
Breast 13 26.5 9 25.7
Lung 6 12.2 3 8.6
Colorectal 16 32.7 15 42.9
Ovarian 1 2.0 1 2.9
Lymphoma 4 8.2 2 5.7
Leukemia 3 6.1 2 5.7
Pancreatic 3 6.1 1 2.9
Bladder 1 2.0 1 2.9
Prostate 1 2.0 -  - —
Unknown primary 1 2.0 1 2.9
Subjects were assessed for the number and types o f care services they received in
the home. More than half the subjects (51%) in the original sample of 49 patients did not
answer this question which may suggest that they are not receiving any homecare services.
Of the subjects that did answer this question, very few were receiving meals (4.2%),
nursing services (8.3%) or other (4.2%). No one was receiving hospice or oxygen
services (see Table 4).
Subjects in the remaining sample of 35 did not rely heavily on any particular
homecare service. Many subjects (51.4%) did not answer this set of questions and a blank
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response was considered a "no" answer. Of those that did answer, no one was receiving 
meals, hospice, oxygen, or other services. Nursing services were used by 2 subjects 
( 11.8%).
Table 3
Characteristics of Subjects’ Home Situation
characteristic original (n=49) remaining (n=35)
n % n %
Residence
House 43 87.8 31 88.6
Apartment 3 6.1 2 5.7
Condominium 1 2.0 1 2.9
Other 2 4.1 1 2.9
Number of persons living with patient
0 10 20.8 6 17.6
1-2 29 60.5 22 64.7
3-6 9 18.8 6 17.6
Number of support oersons
0 10 21.3 6 17.6
1-2 32 68.0 24 70.6
3-5 5 10.7 4 11.7
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Table 4
Care Services Received in Home rn=491
homecare service number %
Meals
Yes
No
No response 
Nursing Service 
Yes 
No
No response
Hospice
Oxvgen
Other
Yes
No
No response
Yes
No
No response
Yes
No
No response
1
22
26
2
21
26
0
23
26
0
23
26
1
22
26
2.0
44.9
53.0
2.0
42.9
53.0
0.0
46.9
53.0
0.0
46.9
53.0
2.0
44.9
53.0
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Subjects were also asked if they had any other medical condition. Of the 
subjects from the original group that answered this question (11 subjects left this question 
blank), 57.9% did not have another medical problem. Diabetes, hypertension and 
migraines were some of the conditions listed by subjects. Most patients (53.6%) in the 
remaining sample group denied having a medical condition other than cancer. Diabetes 
and hypertension were listed by 25.0% of the sample. Table 5 summarizes these data. 
Table 5
Non-Cancer Medical Conditions o f Sample
medical condition original (n=49) remaining (n=35)
n % n %
None 22 57.9 15 53.6
Diabetes 5 13.2 3 10.7
Hypertension 4 10.5 4 14.3
Depression I 2.6 1 3.6
DeepVein Thrombosis I 2.6 — —
Migraines 2 5.3 2 7.1
High Cholesterol 1 2.6 1 3.6
Kidney stones 1 2.6 1 3.6
Back problems 1 2.6 1 3.6
The whole group (n = 49) and the final sample of 35 subjects are comparable in 
gender and age. Both contained more females than males and had a mean age in the mid 
to late 50s. Most subjects lived in homes with support persons. Very few in-home care 
services were utilized by the groups. The majority of patients in both groups denied other
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medical conditions or 6iled to answer the question. Of the other medical conditions listed 
by 16 (32.6%) of the original sample and 13 (37% ) o f the remaining sample, the majority 
were diabetes, hypertension, and migraines.
Instruments
Piper Fatigue Scale. The Piper Fatigue Self-Report Scale (PFS) was used to 
measure the subjective phenomenon o f 6tigue experienced by the cancer patients in this 
study (see permission in Appendix A). The PFS has two forms, the Piper Fatigue Scale- 
Baseline (PFS-B) and the Piper Fatigue Scale-Current (PFS-C). The PFS-B is used to 
measure usual patterns of fatigue and any changes experienced during the six months prior 
to a medical diagnosis or start o f treatment (Piper et al., 1989). Patients are asked to rate 
their fatigue symptoms on a 0-10 point scale, circling the number that best indicates the 
degree to which they are experiencing the feeling or activity (see Appendix D). The 
PFS-C determines fatigue patterns for "now" or "for that day.” The fotigue symptoms are 
measured using a visual analog scale (100 millimeter, horizontal) with each end anchored 
with verbal descriptions. The subjects are asked to place an "X" on the point of the scale 
which best indicates the degree to which they are experiencing the symptom. The PFS-B 
and PFS-C are, for the most part, identical. Some of the questions differ in their verb 
tense reflecting each scale’s temporal focus. This author chose to use the PFS-B as the 
pretest and posttest scale. This assisted in the comparison of the two tests during data 
analysis.
The PFS has seven subscales: (a) temporal, measuring the timing of fetigue; (b) 
intensity/severity, reflecting the severity of fatigue and the degree of distress and 
interference with activities of daily living; (c) affective, reflecting the emotional meaning
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of fatigue; (d) sensory, measuring the physical, emotional and mental sensations 
associated with fatigue; (e) evaluative, assessing what the person believes is the cause of 
the 6tigue; (Q associated symptoms, measuring physical signs and symptoms that occur 
concurrently with fatigue; and (g) relief which measures the perceived effectiveness of 
actions taken to relieve 6tigue (Piper et al., 1989). The subscales are composed of the 
following items: temporal subscale, items 1,3,4 and 5; severity/intensity subscale, items 2 
and 6-16; affective subscale, hem 17; sensory subscale, 18-35; evaluative subscale, hem 
36; associated symptoms subscale, hems 38-39; and relief measures subscale, hem 37. 
The hems from subscales temporal (excluding hem 3), severhy/intenshy, affective, and 
sensory are used to calculate the total fatigue score based on earlier psychometric testing 
by Piper et al. The subjects’ responses to these hems are summed and divided by four. 
The higher the score the greater the fatigue experienced by the subject. Scores may range 
from a minimum of 0 to a maximum o f400.
The validity of an instrument refers to the degree to which an instrument 
measures what h is supposed to measure (Polh & Himgler, 1991, p. 374). Construct 
validity was established for the PFS-B by Piper et aL (1989). Using the Profile of Moods 
States (POMS) and the Fatigue Symptom Checklist (FSCL), convergent and discriminant 
validity were also determined. Moderate convergent validity was supported by a 
coefBcient of .55 (p < .001) between the general mean intensity o f the FSCL and the 
affective subscale of the PFS and the validity coefficient of .54 (p< .001) between the 
general symptoms subscale of the FSCL and the affective subscale of the PFS. Moderate 
discriminant validity was determined by a coefficient of -.57 (p< .001) between the 
sensory subscale of the PFS and the vigor/activity subscale of the POMS. For the
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purpose of the validity study conducted by Piper et al. (1989) the total fetigue score was 
calculated on the scores o f four subscales (temporal, severity, affective and sensory). The 
other three subscales (evaluative, associated syn^)toms and relief) were determined not 
essential to the measurement of subjective fetigue when reviewed by 11 fetigue experts in 
regards to content validity (Piper et aL, 1989).
Reliability is the degree of consistency with which an instrument measures the 
attribute it is supposed to be measuring (Polit & Hungler, 1991, p. 367). Piper et al. 
(1989) used Cronbach's alpha to measure internal consistency. The reliability coefficients 
ranged from an alpha o f .69 for the associated symptoms subscale to .95 for the sensory 
subscale. The reliability estimate for the total fatigue score was .85 (calculated on the 
temporal, severity, affective and sensory subscales only). Reliability of the total fetigue 
score for this investigation was established at .97 using Cronbach's alpha.
Demographic information sheet. A demographic information sheet was 
developed by the author to gather demographic information about the sample (see 
Appendix E). The questions were reviewed by an oncology Clinical Nurse Specialist for 
their appropriateness to the phenomenon o f fatigue in cancer patients.
Procedure
Prior to the start of data collection, an inservice (Appendix G) was held with the 
clinic registered nurses (RNs) giving them information about the study, how to approach 
a potential study participant, how to offer them the opportunity to participate in the study 
and how to obtain consent (see Appendix F). The researcher prepared a script for the 
RNs to read when offering participation into the study (see Appendix H). A written 
outline with the basic step by step instructions of how to proceed once a patient had been
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placed on study was available for easy reference during busy clinic hours. The RNs had 
the opportunity to ask questions at this inservice and were informed that the researcher 
would be available by phone at any time throughout the study. The researcher visited the 
clinic two to three times per month to monitor progress of the study, assess potential 
subjects' eligibility, reinforce iir^ortance of keeping control and experimental information 
separate, and to answer any questions the RNs had. When the location of the study 
moved from the hospital-based clinic to the private office, the same inservice was given to 
the new RNs assisting in data collection. Two of the clinic RNs originally involved in the 
study took positions at the new center and were, therefore, able to continue the study with 
some level of consistency. The researcher provided the other three RNs with the same 
inservice given prior to the start of data collection.
Potential subjects were identified and screened for eligibility by the researcher 
and participating RNs prior to their scheduled appointment at the outpatient chemotherapy 
clinic. Once a patient agreed to participate, the RN obtained the master form and wrote 
the patient's name on the next line which then identified the patient number and group they 
were randomized to. The patient packets were precoded by the researcher. The RN then 
took the packet, obtained written consent for study participation and had the patient fill 
out the PFS-B.
The treatment involved in this experimental study was the implementation of a 
nursing intervention designed to fecilitate adaptation to the fetigue associated with 
chemotherapy by impacting the patient’s acquired coping mechanisms. The typical 
chemotherapy patient education given to the control group combines written and verbal 
information. The written information includes the Chemotherapv and You booklet
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(National Institutes of Health, 1990), a general information sheet, and specific drug 
literature (see Appendix B). The RN then verbally highlighted some of the more 
important information individualized to each patient, and his or her diagnosis and 
treatment regimen. Often general statements are given regarding the expectation of 
fetigue associated with chemotherapy. For example, "Chemotherapy can lower your 
blood cell counts. You therefore may experience some fetigue. Many patients find they 
need to rest more often."
The early nursing intervention given to patients in the experimental group 
supplemented the typical education patients receive regarding fetigue. A pamphlet 
describing the possible causes o f fatigue, specific suggestions to help alleviate fatigue and 
verbal reinforcement of the information was given to the experimental group patients (see 
Appendix C). Patients were asked if they had any questions regarding fatigue. The 
teaching involved in the experimental group took approximately five to ten minutes.
The Piper Fatigue Scale and the experimental nursing intervention (or standard 
nursing intervention) were administered on patients' initial visit to the outpatient 
chemotherapy clinic for their first chemotherapy treatment and prior to release fi'om that 
day’s clinic appointment. The Piper Fatigue Scale was administered again after two cycles 
of therapy (on the first day of the third cycle) prior to a patient’s release from that day’s 
clinic appointment.
Potential Risks and Methods to Reduce Those Risks
As with any research process, a variety of risks are possible. The potential risks 
to patients in this study included confidentiality issues, additional stress, and loss of time 
and fatigue in completing the questionnaires.
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Confidentiality was maintained to the best of the researcher’s ability. All data 
collected were numerically coded. There was only one master form that identified patients 
by name. This was destroyed after all requirements for this project were fulfilled. The 
subject’s name was not attached to any of the 6tigue scales nor did it appear in any of the 
results. All data presented is in group form.
Newly diagnosed cancer patients are understandably overwhelmed with the many 
new situations they fece, especially their first day of chemotherapy. Some patients, 
especially the elderly, declined participation in the study for this very reason. One of the 
clinic RNs, who put the majority of patients on study, stated that approximately six 
patients declined participation because they felt "bombarded" with information. These 
patients were not pressured to participate in the study and were encouraged to verbalize 
their feelings. Other patients welcomed the chance to take an active role in a research 
study that may potentially benefit themselves as well as future cancer patients.
Although the research process did not keep patients in the clinic any longer than 
they would be normally to receive their treatment, patients were allowed to take the 
survey home if they were scheduled to return to the clinic the next day. Patients 
complained that the scale was too long and that it had redundant questions. Some patients 
even made written comments on the survey itself that they had increased fatigue due to the 
length of the survey. Every attempt was made to ensure full understanding of the study 
and fetigue scale forms and an RN was nearby to answer any questions. They were 
allowed to withdraw firom the study if they found participation too burdensome.
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CHAPTER 4 
DATA ANALYSIS
Of the original 49 patients participating in the study, 4 died before completing 
the posttest, 3 were taken off their chemotherapy regimens before completing the posttest, 
4 completed 64% or less of the pretest or posttest, and 3 Êiiled to complete the posttest 
altogether. An equal number of males (7) and females (7) were dropped from the study. 
Nine of the lost subjects came from the experimental group whereas only 5 came from the 
control group. These and other subject characteristics are summarized in Table 6.
In addition to the high drop out rate, there was a large amount of missing data. 
Subjects had not been informed of the importance of completing the entire survey and this 
was evident by the fact that very few subjects completely filled out both the pretest and 
posttest. Polit and Hungler (1995) address the issue o f missing data in nursing research. 
Before selecting one of five approaches, it is important to first determine the distribution 
and patterning of the missing data (Polit & Hungler, 1995). By using Chi-square and 
Fisher's Exact test the researcher found no pattern in the missing values. It was 
determined that the missing data were random and that two separate populations were not 
sampled among those that completed or did not complete the study. One of the 
approaches described by Polit and Hungler (1995) is to substitute the mean value for the 
missing values. This is a particularly useful method when the missing values come from a 
multiple-item scale, like the Piper Fatigue Scale. The mean was therefore used to replace
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Table 6
Characteristics o f Subjects Dropped from the Study fn=14')
Characteristic
Number of Subjects 
Experimental Control
(n=9) (n=5)
Age (years)
31-40 0
41-50 2
51-60 1
61-70 2
71-83 4
Gender
Male 4
Female 5
Type of Cancer 
Unknown primary 0
Pancreatic 0
Lymphoma 3
Colorectal 1
Breast 3
Lung 2
Reason for Drop Out 
Deceased 2
Off Chemotherapy 2
> 35 % of survey incomplete 3
Failed to complete posttest 2
1
1
1
2
0
3
2
1
2
0
0
1
1
2
1
1
1
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the missing values on all surveys with less than 35% data missing. If more than 35% of 
the survey was not con^ieted, the subject was dropped from the study. As noted in Table 
6, three experimental group subjects and one control group subject were eliminated from 
the study for this reason.
Complete data were collected on 35 subjects. The experimental group had 16 
subjects and the control group had 19 subjects. There were 8 males and 8 females in the 
experimental group. In sharp contrast, the control group had only 4 males and 15 females. 
Table 7 summarizes these characteristics as well as providing information regarding the 
types of cancer in each group.
It is well documented that fatigue is prevalent no matter what type of 
chemotherapy regimen patients are receiving. However, other important information may 
come from further research that controls for this variable. The chemotherapy regimens of 
the experimental and control groups are therefore listed in Table 8.
Other variables that could potentially affect a person’s level of fetigue were 
assessed. Issues such as where people reside, how many people live with them and how 
many of those they could rely on for support, homecare services, and other medical 
conditions are reported in this study. It is interesting that very few subjects had any type 
of homecare services. Perhaps the eligibility criteria for this study disqualified the subjects 
more likely to have these services, such as the end-stage patient who has repeatedly failed 
chemotherapy (i.e.,they are more likely to have had chemotherapy within the last year and.
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therefore, be ineligible for study participation). The data describing other variables that 
could affect a person’s level of 6tigue are displayed in Tables 9 (Home Situation), 10 
(Homecare Services), and 11 (Other Medical Conditions).
Table 7
Final Sample Characteristics (if=35)
Experimental
(n=16)
Control
(n=19)
Attribute n % n %
Aee fvears)
19-40 4 25.0 3 15.8
41-50 0 0 3 15.8
51-60 4 25.0 3 15.8
61-70 5 31.2 7 36.8
71-83 3 18.8 3 15.8
Gender
Male 8 50.0 4 21.1
Female 8 50.0 15 78.9
Tvpe of Cancer
Breast 4 25.0 5 26.3
Lung 1 6.3 2 10.5
Colorectal 9 56.3 6 31.6
Ovarian 0 0 1 5.3
Lymphoma 0 0 2 10.5
Leukemia 1 6.3 1 5.3
Pancreatic 1 6.3 0 0
Bladder 0 0 1 5.3
Unknown primary 0 0 1 5.3
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Table 8
Chemotherapy Regimens fn=35^
Chemotherapy Regimen
Experimental
(n=I6)
Control
(n=19)
5FU/Leukovorin 8 4
5FU/Levamisole 2 2
CMF 0 3
CAP 4 2
Carbo/Taxol 0 I
VP16/Carbo 1 1
MVAC 0 1
Carbo/CTX 0 1
CHOP 1 1
CTX/VCR 0 I
MOP? 0 1
V elban/Estramnstine 0 I
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Table 9
Variables of Home Situations That Might Affect Fatigue
Experimental Control
Variable n % n %
Residence
House 13 81.3 18 94.7
Apartment 2 12.5 0 0.0
Condominium 0 0.0 1 5.3
Other 1 6.3 0 0.0
Number of Persons Living with Subiect
0 4 26.7 2 10.5
1-2 8 53.3 14 73.7
3-5 3 20.0 3 15.9
Persons for SuDOort
0 4 26.7 2 10.5
1-2 9 60.0 15 79.0
3-5 2 13.4 2 10.6
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Table 10
Use of Home Care Services Among Experimental and Control Groups
Variable
Experimental 
n %
Control
n %
Meals
Yes 0 — 0 —
No 7 43.8 10 52.6
No response 9 56.3 9 47.4
Nursing Service
Yes 0 — 2 10.5
No 7 43.8 8 42.1
No response 9 56.3 9 47.4
Hospice
Yes 0 — 0 —
No 7 43.8 10 52.6
No response 9 56.3 9 47.4
Oxygen
Yes 0 — 0 —
No 7 43.8 10 52.6
No response 9 56.3 9 47.4
Other
Yes 0 — 0 —
No 7 43.8 10 52.6
No response 9 56.3 9 47.4
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Table 11
Medical Conditions That Might Affect Fatigue
Experimental Control
Variable n % n %
None 6 54.5 9 52.9
Diabetes 2 18.2 1 5.9
High Cholesterol 1 9.1 0
Hypertension 0 — 4 23.5
Kidney stones 1 9.1 0
Depression 0 — 1 5.9
Bad back 1 9.1 0
Migraines 0 — 2 11.8
Hypothesis
The hypothesis for this study was: the intervention group would subjectively
adapt to the fatigue experience associated with chemotherapy more positively, as
measured by scoring lower on the Piper Fatigue Scale, than the control group. Both the
experimental and control groups pretest and posttest scores were totaled and used to
compare the two groups. Parametric tests included the paired and independent t-test and
ANCOVA. Based on preliminary findings, further paired and independent t-tests were
done. The findings do not support the research hypothesis.
The total scores on the PFS ranged firom 1 to 293 (see Table 12). Using a paired
sample t-test, the relationship between the samples' pretests and posttests was examined.
There was a significant increase in the pretest to posttest scores of the entire sample. The
mean pretest score was 95.03 (s.d.= 67.72) and the mean posttest score was 126.57 (s.d.=
45
78.41) (t= -2.58, d.f .=34, p= .014). As expected, this shows the progression of fatigue 
for this group of cancer patients receiving chemotherapy. Independent sample t-tests 
showed no significant difference between the experimental and control groups’ pretest. 
The experimental group’s mean pretest score was 96.69 (s.d.= 83.94) and the control 
group’s mean pretest score was 93.63 (s.d.= 52.78) (t= .13, d.f.= 24.4, p= .901). The 
posttest scores also showed no significant difference. The experimental group had a mean 
score of 124.87 (s.d.= 91.10) on the posttest and the control group 128.00 (s.d.= 68.50) 
(t= -.12, d.f. = 33, p= .909).
Table 12
Piper Fatigue Scale Scores
TEST
NUMBER OF SUBJECTS 
Experimental Control
Pretest
1-74 9 7
75-150 3 9
151-225 1 3
226-293 3 0
mean 96.69 mean 93.63
Posttest
1-74 6 4
75-150 3 7
151-225 5 6
226-293 2 2
mean 124.87 mean 128.00
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A paired sample t-test was then used to examine the relationship between the 
pretest and posttest scores for the experimental group as well as for the control group. 
The experimental group scores showed no significant difference between the two times ( t 
= -1.27, df= 15, p = .224) but the control group scores did (t = -2.61, df = 18, p =
.018). This suggests that the control group had significantly more fatigue firom pretest to 
posttest.
Analysis of covariance was used to compare the two groups posttest scores 
while controlling for the pretest. A significant differencewas found between the pretest 
and posttest scores (F = 11.73, p = .002). No difference was found based on group 
membership (F = .04, p = .834) (Table 13). The variation explained by the nursing 
intervention was small (R-squared = .268).
Table 13
Analvsis of Covariance for Posttest Fatigue Scores
Source of Variation d.f. MS F P
Between groups 1 213.36 .04 .834
Covariate 1 56043.40 11.73 .002
Within groups 32 4779.26
Additional Analysis
Pearson's r was used to examine the relationship between age and the pretest and
posttest scores. A moderate inverse relationship which approached significance was
found between the age of the subject and the pretest ( r = -.30, df = 35, p = .074) and
posttest ( r = -.31, df= 35, p = .066) scores. This suggests that younger subjects may
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have experienced greater fetigue. Another Pearson's r examined the correlation between 
age and the number o f people living with the subject. Again, a significant inverse 
relationship was foimd (r = -.4554, df = 34, p = .007). The younger the patient the more 
people lived with the patient.
The intriguing findings regarding young patients experiencing more fetigue led to 
more analysis o f data. Paired sample t-tests showed a significant difference between the 
pretest and posttest scores for women (pretest mean 97.35 [s.d. = 71.58]; posttest mean 
134.52 [s.d. = 84.74] [t = -2.23, d f = 22, p = .036]) but not for men (pretest mean 90.58 
[s.d. = 62.39]; posttest mean 111.33 [s.d. = 65.26] [t = -1.26, df = 11, p = .233]). The 
subjects were then broken down into two age groups: a younger age group (ages 19-60) 
and an older group (ages 61-79). T-tests showed a significant difference from pretest to 
posttest in the younger group (t = -3.58, df = 16, p = .003) but not in the older group 
(t = -1.10, df = 17, p = .288). Independent sangle t-tests showed no significant difference 
between the young and old groups on the pretest (t = 1.04, df = 33, p = .305) or the 
posttest (t = 1.55, df = 33, p = .132).
Subjects identified causes of 6tiguG and relief measures they used. The 
chemotherapy treatment, sleep disturbance, and cancer were the three most common 
causes of fatigue listed by subjects on the PFS. Other reasons for fetigue included pain, 
coping, and the post-operative recovery process. The primary relief measure was rest, 
such as relaxing, napping, or getting a good night’s sleep. The next two most frequently 
identified relief measures were positive reading and thinking and prayer/bible study. It is 
interesting that none of the subjects in this study identified delegating tasks as a relief 
measure.
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CHAPTERS 
DISCUSSION AND IMPLICATIONS
Hypothesis
The purpose of this study was to investigate whether an early-nursing 
intervention, the handing out and discussing of information regarding fatigue, could help 
patients subjectively adapt to the fotigue associated with chemotherapy. The findings 
presented in this study did not support the hypothesis. Both the independent t-tests and 
ANCOVA showed no significant differences between the experimental group and the 
control group scores. It is interesting to note that the control group’s mean fetigue score 
on the pretest was lower (93.63) than the experimental groups (96.69) and that their mean 
posttest score was higher (128.00 for control and 124.87 for experimental). These value 
differences were not significant, however, a larger sample and reinforcement of the 
information on the brochure during the course o f the study may strengthen the study and 
the results.
Additional Findings
Interesting and valuable information did emerge firom the data analysis. Paired t- 
tests showed significant differences between the pretest and posttest for women (p=.036) 
but not for men (p=.233). This finding led to questions such as: Are there multiple role 
issues that occur for female patients? Are women more comfortable expressing their 
feelings and therefore more apt to report their level of fatigue through the PFS?
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Lee, Lentz, Taylor, Mitchell, and Woods (1994) examined fatigue as it related 
to women's lives, particularly their internal and external environmental demands. They 
found no significant relationship between the severity of 6tigue and age (an internal 
demand). The internal environmental demands that showed the strongest correlations with 
fetigue were anxiety ( r = .239, p < .001) and depression ( r = .231, p < .001). A 
significant relationship was found between 6tigue and the external environmental demand 
called Negative Life Event ( r = .177, p =.002). Of course, a diagnosis o f cancer and 
subsequent treatment with chemotherapy is considered a negative life event. No other 
external environmental demands, such as positive events, role behavior including parenting 
and homemaking, or conflicting social support, correlated significantly with 6tigue in 
these women.
Another study by Libbus, Baker, Osgood, Phillips, and Valentine (1995) looked 
at fatigue in healthy women. Their objective was to identify relationships of behavioral, 
socio-demographic, and emotional fectors among women generally thought to be healthy 
who complained o f persistent fetigue. They used an investigator-designed survey to 
gather demographics, the Piper Fatigue Scale (PFS), and the Beck Depression Inventory 
to assess subjective fetigue and depression, respectively. Women who perceived 
themselves as having difSculty coping with stress had higher levels of fatigue. The authors 
suggest that this finding could indicate that women become less able to handle stress as 
their level o f fetigue increases. No significant relationship was found between women's 
fetigue scores and either the percent of responsibility for household tasks or number of 
hours worked at a job outside the home. This finding supports Lee et al. (1994) study 
which found women's internal demands to correlate with fatigue better than external
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demands. Clearly these findings do not support the theory of multipie-roles as the cause 
of increased &tigue in the women o f this study sample.
Paired t-tests on the younger and older groups of the sample showed a 
significant difference between the younger group (p=.003) but not the older group 
(p=.288). Questions that arose from this finding included: Do older patients, many of 
whom are retired, have more time to rest? Do younger patients feel more tired because 
they do not expect nor have they usually experienced such physical exhaustion before? 
Perhaps the older patient, who is more likely to have suffered a physical ailment, has to 
adapt less than the younger patient.
Graydon, Bubela, Irvine, and Vincent (1995) reported on the fatigue-reducing 
strategies used by cancer patients. In this study, an interesting correlation between age 
and fatigue was found. The older the subject, the greater the relief of fatigue at the second 
interview (r = 0.21, p < 0.05). Other than to report the correlation, the authors did not 
discuss this finding further. As mentioned earlier, Lee et. al. (1994) found no significant 
relationship between the severity of fetigue and age. Further investigation, including 
focusing on age of subject, methods o f coping, and previous adaptation to physical and 
mental stressors will need to continue.
Relationship o f Findings To Conceptual Framework
The findings o f this study do not support the intent: that the outcome of positive 
adaptation be enhanced. Roy's theory is holistic and therefore complex. Fatigue and the 
mechanisms that produce fatigue are also very complex. This study focused on and tested 
for the complex nature o f fatigue, hoping to capture all that was needed to assist patients 
to adapt to this severe side effect. There are obviously other factors, residual stimuli as
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well as contextual stimuli, that influence and impact a patient’s level of &tigue. Perhaps 
assessment for contextual stimuli takes longer than this study allowed for. Often this type 
o f information is elicited once a rapport has been built with a patient. Perhaps there is 
residual stimuli common to certain groups (such as young women) that have yet to be 
uncovered.
There is also the control processes aspect o f Roy’s model. While this study 
focused on the acquired coping mechanisms there are the genetically determined innate 
coping mechanisms. Again, a group of people (such as young or old, male or female) may 
cope and, therefore, adapt better or worse than another group. Patients may have also 
needed more reinforcement of the information regarding fetigue. Perhaps the acquired 
coping mechanisms need time to develop.
Reinforcement of this information may need to be done over and over, especially 
considering that the patients received it on their first day of chemotherapy, a day full of 
new information. Incorporating more effort into identifying as many of the residual and 
contextual stimuli as possible and reinforcement o f the fetigue information throughout 
chemotherapy treatments may have achieved better results.
Roy's adaptation model was a useful tool that assisted in the theoretical design of 
this study. The model served to organize a plan to assist patients to adapt to fatigue, and 
in light of the findings, also served to guide future research as adjustments in the research 
process can be made based on Roy’s model.
Limitations
This study used a small (n = 35), convenience sample. Therefore, findings can 
only be generalized back to this sample. In addition, the large amount of missing data and
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dropout rate hindered aid data analysis. Although a rigorous process was used to deal 
with the missing data, complete data would have made for a larger final sample. It also 
may have been beneficial to have the same RN (or researcher) to assist all subjects in 
completion of the surveys. Unfortunately, this is not always possible in a last-paced clinic.
In view of the research findings regarding women and 6tigue, it would have 
been helpful to add the Beck Depression Inventory or similar scale. However, many 
subjects complained that the PFS was already too long, redundant and, for lack of a better 
word, "nonsense." The researcher believes this viewpoint contributed to the amount of 
missing data. Having someone very femiliar with the PFS present during the time when 
patients were filling out the surveys may have assisted patients to understand the rationale 
behind the PFS. Many subjects were overwhelmed by having to fill out the PFS on the 
first day of chemotherapy. There may be a better time to fill out the PFS other than the 
first day of treatment although it is important to assess the fetigue level prior to the start 
of therapy. To add another scale, such as the Beck Depression Inventory may have 
proved even more overwhelming for subjects.
The PFS is composed of 7 subscales yet only 4 of these subscales are used to 
obtain a fetigue score. To eliminate the other 3 subscales would not considerably shorten 
the PFS. The evaluative, timing, and associated symptoms subscales comprise 4 open- 
ended questions that allow for valuable assessment data for nurses.
Data collection took 11/2 years because more patients were receiving concurrent 
radiation than the researcher anticipated. This excluded a large number of potential 
candidates for study participation. Each patient that was placed on study took 
approximately 3 months to complete the pretest and posttest. The time frame for data
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collection allowed for a greater threat of history. Many things were happening in the 
oncology arena regarding &tigue during this time. The Oncology Nursing Society held 
the Fatigue Initiative through Research and Education (FIRE). The pharmaceutical 
company sponsoring FIRE provided free literature to oncology patients regarding fetigue, 
its mechanisms, and interventions to help alleviate it (generally the same information 
presented in the fetigue pamphlet). Although the researcher was aware of this information 
and tried to maintain experimental conditions, it is easy to see that information of this 
type may have reached the study subjects (both experimental and control).
Data regarding the status of subject’s co-existing diseases (such as diabetes, 
cardiovascular disease, or depression) and/or physiological causes of fetigue (such as 
anemia) were not gathered or statistically controlled for. Questions arose about whether 
these physical states had an impact on the total fatigue score? Measures for these 
conditions could have been gathered (such as the routine CBCs for anemia) or added 
(such as the Beck Depression Scale) but this author believed fetigue to be universal in the 
chemotherapy population, even in patients without evidence o f concurrent disease or 
physiological changes. Theoretically, random assignment should eliminate concerns 
regarding co-existing disease and physiologic causes but future researchers may want to 
assess the impact of underlying medical conditions and physiological causes on fatigue 
more carefully.
Implications for Nursing
Practice. The prevalence of fetigue in cancer patients is not disputed and this 
study afiBrms this as well. The findings clearly point to the need to continue to holistically 
assess for chemotherapy-induced fatigue. Roles, stressors, coping mechanisms, and
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supports should be included in order to assure the best possible outcome for each 
individual. Teaching patients that getting them through chemotherapy-induced 6tigue is a 
team effort, that no intervention will alleviate all o f their feitigue, and that what they are 
experiencing is normal are avenues for hope and success.
Nurses also need to be mindful of different groups within the chemotherapy 
population. Findings o f this study point to very different needs based upon age, sex, and 
perhaps other attributes. Although all the information regarding different groups is not yet 
available, keeping in mind that there are most likely significant differences can assist in 
positive outcomes until we know more.
Education. Educators need to be aware o f the trends in nursing. Fatigue and 
other quality of life components are issues that nurses are focusing on in the 1990s. 
Educating nurses regarding the theories about these issues is vitally important. Holistic 
assessment must be taught to nurses so that appropriate interventions can be implemented. 
This allows for the best possible outcomes. Finally, timely follow-up and evaluation are 
skills every nurse needs to incorporate into his or her practice.
Administration. Administrators also need to be aware of the trend focusing on 
fatigue. This allows them to encourage RNs to attend conferences and workshops 
regarding quality of life issues such as fetigue. Administrators can promote the 
dissemination of information and literature regarding fetigue to the RNs under their 
direction through task forces, bulletin boards, and journal review clubs. The nursing 
profession as a whole needs to continue striving to understand the patterns, causes, and 
effects o f fetigue. This wül only benefit future patients.
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Implications for Research
Fatigue has become a priority issue, especially in oncology nursing research. It is 
a side effect that diminishes quality of life for the majority of cancer patients and requires 
nursing to understand and, hopefully, control it better. The interest in fetigue is 
tremendous and research will continue. There are so many aspects o f fetigue that need 
attention, as this study demonstrates. Questions include: Why does the level o f fatigue 
vary from person to person, even if type o f  cancer and chemotherapy regimen are 
controlled for? Why is fetigue subjectively rated higher for younger women than for 
younger men or older men and women? These and countless other questions need to be 
addressed in friture research studies.
As is often the case in nursing research, a larger sample would have decreased 
the sampling error and increased the confidence in generalizing the results. Future studies 
would hopefully draw a large number of chemotherapy patients from a variety of hospitals 
and clinics thereby decreasing the sampling error and increasing the sample size. A power 
analysis may also help determine how large a sample is needed to detect what may be a 
small difference between outcome variables. Polit and Hungler (1991) suggest 100-300 
subjects in each group (for a total sample o f200-600) to detect a small to moderate 
difference in outcome variables.
Changing the research procedures might also clarify the results. It may be 
beneficial to add a third survey at the sixth cycle o f chemotherapy or skip the third cycle 
posttest and perform the posttest at the sixth cycle. This, however, would increase the 
length of time of data collection.
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Throughout the chemotherapy courses, RNs could continue to reinforce the 
information in the brochure, referring to it casually during chemotherapy administration. 
This may help increase the likelihood that the patient assimilates the information regarding 
fatigue and, therefore, utilizes the information to help himself or herself adapt to 6tigue.
The PFS was also noted by the subjects of this study to be quite lengthy and 
tiresome. Unfortunately, eliminating 3 of the 7 subscales only reduces the survey by 4 
open-ended questions. The majority of the PFS would still need to be completed.
Perhaps future researchers could assess or develop other 6tigue scales for their length and 
appropriateness in this population of patients or assist patients in completing the PFS. 
Assessment of concurrent medical and physiological conditions should also be done.
Many routinely collected measures like CBCs can be assessed. Consideration to the 
addition of scales like the Beck Depression Scale should also be given. This may add 
support to the need to develop or find a more concise instrument to assess fatigue. 
Summarv
The prevalence of fetigue in cancer patients will not diminish until more 
knowledge regarding fatigue and its mechanisms is obtained. Adaptation to fatigue was 
assessed as a possible relief measure in this study. The findings did not support the 
hypothesis but that should not discourage future research about adaptation and fatigue. 
Both are very complex processes and may require numerous studies before yielding data 
that will directly benefit patients. The Roy Adaptation Model proved useful in the 
theoretical design of the study and can guide future nursing research regarding fatigue.
All realms of nursing should continue to focus on fatigue and other quality of life issues as 
these are so important to the quality of care patients receive.
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Dear CoUeague:
Thank you for expreaalng Intereat in uaing the "Piper Fatigue Scale* 
(PFS). The instrument contains 41 horizontal visual analogue scale 
(VAS) items that measure four dimensions of subjective fatigue; the 
temporal dimension (6 items), relating to the timing, flrequency. 
pattern and duration of fa ti^ e; the intensity/severity dimension 
(12 items), relating to the severity, distress and degree of 
disruption in activities of daily living; the affective dimension (5 
items), relating to the emotional meaning attributed to fatigue; and 
the sensory dimension (19 items), relating to the pt^sical. emotional 
and mental symptoms of fatigue'.
Individual subscaie and total fatigue scores are calculated and 
range firom "0" to *100". Four additional "open-ended* items are 
included that identify perceived causes, relief measures, associated 
symptoms and additional fatigue descriptors.
Reliability^and=validity estimates have been calculated for . breast 
and lung cancer patients receiving radiation therapy (RT) and 
breast cancer patients receiving chemotherapy (CT). In these 
samples, internal consistency reliabilities (ONRtoeh'§ ilp lii) HRgg 
firom .80 to .96; concurrent validity estimates (correlations between 
PFS. Fatigue Symptom Checklist and Profile of Moods State scores) 
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for further development of the PFS such as age and sex 
characteristics; subscaie and total fatigue scores; and reiiability- 
vaiidity estimates if calculated. A copy of the final manuscript also 
would be appreciated.
To receive a copy of the PFS. two articles describing the 
development and testing of the PFS and additional information on 
how to order the digitizer and software program, please forward a 
cashier's check in the amount of 126.00 to the above address.
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1 mm delighted that you are interested in studying fatigue and I 
look forward to reading about your contributions in the literature. 
If I can be of further assistance, please contact me.
Since]
Bferbara P. Piper. S.N.: 11.8.'
Doctoral Candidate, U.C.8.F. School of Nursing and 
Oncology Staff Nurse, U.C.S.F./Mt. Zion Medical Centers.
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APPENDIX B
Standard Chemotherapy Patient Information
APPENDIX B
GENERAL IHFORMATIOM WHEN RECEIVING CHEMOTHERAPY
1. I f .  you h«vc any qutaclona o r eonetrns c a l l  cha Sc. M ary'a Ragional Cancer Cancer 
ac 774-6714. The cancer l a  open Monday ehcough Friday from 8:00 an co 4:30 pm. 
Any aaergenelea chac occur ac ocher clmaa w il l  be handled by che physic ian  who 
la  "On C all" . jCall your o n eo lo g lac 'a  o ffic e  number and che answering se rv ice  
w ill"concacc che doecor f o r  you.
Dr. Sobong/Dr. Yosc/Dr. Scocc 774-8200
Dr. 'Karks/Dr. Ovlacc/Dr. Anderson/Dr. O 'Donnell 456-7892
D r. 'SanOtego 774-4446
Dr. N.Campbell/Dr. A.Campbell 942-1310
2. I f  you ever need co c e l l  che RCC o r your doccor wlch e problem, take your camper- 
-acure f l r s c .  You w i l l  need co buy a ehecaomecer I f  you do not own one. Always 
c e l l  I f  your temperecure la  100 degrees or g re a te r ,  o ra l ly  no m atter what elm e'o: 
day or-n lghc, weekend o r ho liday  I You may have an In fe c tio n . Signs and symptom: 
of In fec tio n  include *
a . Shaking c h i l l s  a re  o fte n  a sign  of a ra p id ly  r is in g  tem perecure.
I f  these occur cake your temperature Immediately and c a l l  your 
doecor I f  I t  la 100 degrees or g re a te r .
b . Foul sm elling , cloudy o r  bloody u rin e , pain and/or burning upon 
u rin a tio n .
■c. P e rs is te n t cough, productive cough (e s p e c ia l ly - I f  phlegm Is green) 
wlch or w ithout accompanying cheat pain .
d . Reddness, sw elling  end /o r peln enywhere e lse  ( e .g . :  an old IV s i t e  
or a stubbed toe chac w i l l  not h e a l) .
3 . Headache and/or s t i f f  neck wlch accompanying-fever.
A* Remember: Always c a l l  I f  your not fee lin g  w ell and have a feverl111
3 . Nausea and Vomiting: You may f e e l  nauseated fo r one to  two days a f te r  your chem 
therapy . Always c a l l  I f  you a re  caking che m edication fo r  nausea- and a re  s t i l l  
fe e lin g  nauseated. Here a re  some ways co help prevent o r minimise nausea (esp . 
fo r  the f l r s c  24 hours a f t e r  receiv ing  your treatm ent)T
a. I f  given a p re sc r ip tio n  fo r compaslne, phenergen, to rcan  or t lg a n ,  
take one tab  every 4-6 hours around-the-clock (except when sleep ing) 
fo r the f i r s t  24 hours a f te r  receiving chemotherapy. Then take one 
tab every 4-6 houps as needed. (Always READ and FOLLOW the d ire c tio n s  
on the p re sc lp tlo n  la b e l I f  d if fe re n t than above).
b . Eat a l ig h t  d in n e r. Avoid eating your fa v o r i te  foods o r sp icy , greasy 
, foods.
c . Rest once you've a rr iv e d  home. Take I t  e e a y lll  Watch TV or read a 
a good book.
4. Inform your oncologist of a l l  m edications th a t you cake. A sp irin  and any Ibuprc 
product (M otrin, Advil and Nuprin) Increase b leed ing . DO NOT TAXE these  un less 
check,w ith your o n co lo g is t. For minor aches and pains take Tylenol.
5 . C a ll I f  any skin rashes appear and do not c le a r  up. Avoid excessive exposure tc 
the  sun I f  receiv ing  c e r ta in  chemotherapeutic agente. See drug handout shee ts
fo r  various side e f fe c ts  a sso c ia ted  wlch each agen t. —
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7. Ceo4 Bouch ear* la Important, tnapaet your mouth dally and waa a aoft tooth- 
bnab a lta r  avary maal. Rlsa* wall a lta r  brwahlo; with aa lt and aoda rlnaai at 
laaat Ixpar day (1 tap of aa lt plua ona tap. of bafclnp aoda jn_ $ or. to ena 
pint of watar).. Thla can pravant and/or halp haal mouth toraa that aeaatlaaa 
aeeompany ehamotharrpy traatmant. flaaaa ca ll If  tha foilewln* eceura: :
a. Mouth aorta which do not iaprova with aa lt and' aoda rlnaaa.
b. tavara mouth aorta that Itel.t or pravant you from aatln; or drinking.
c. Uhlta patchaa In your mouth.
6. Avoid alcoholic drlnka on the day of chamocharapy. Alcohol dahydrataa your body 
of fluIda naadad to halp fluah out tha cbasotharapy. -Unlaaa contralndleatad by 
your doctor for other health raaaona, Incraaatn# your fluid Intake while o n ^  
chamocharapy la beneficial,
9. Your walght w ill be chackad on each v la l t .  Do not begin any weight lore diet with-, 
out conaultlng your oncologlat. A wall balanced high protein diet la vary important 
to halp normal calla repair thamaalvaa.
ib . Diarrhea can occur with chamotharapy. You may try evac-tba-ceunttr Kaopactata aa 
directed. Call i f  diarrhea paraîtra or If  you arc hiving greater than 2-3- looaa 
atoola par day.
11. .Pain p illa  may conaclpata you. Drinking a lo t of flulda and eating a high fiber" 
and roughage diet la Important. Call If  conatlpatlon paralata
12. Ua have numanoua pamphlata and matarlala fra* of'charge for you. Atfc If you would 
Ilka to read aoma Information about your cancer mid traatmant.
13. If you raealva aoma of your chamocharapy In tha hoaplcal and tha doctor te lle  you
to go to tha Regional Cancer Canter for laba or a follow-up appointment, CALL
Xhlrlay and make an appointment at 774-6714,
14. [ i f  you,.nd*a to^ÿbdi^your p— i “*M R between 8:00 am "and 
Monday throujfr-Pi lilipi (ffirtTfon, RPh. 774-66?87>>.J I  I t  la an emergency
and after hour* or tha weekend, ca ll your oncologlat.
13. For Dr. Sobong/Yoac/Scott patienta: Once you have completed your chemotherapy
treatment* you w ill be een a t the Ramona office (SIS Lakeaide Dr. S.C.). After 
your f lr a t  appointment Chare, a l l  calla ahould be made to 774-8200. If you .are 
unable'to gat ahold of aomeona, wa arc alwaya happy to aaalat you in any way wa can. 
• .
16. If you have now or at anytime have financial problem*, pleaae le t ua know, wa may
be able to offer acme aaalatanca. Alao, do not be embatraaaed to ask queatlona
regarding your sexuality (Intimate rclctlonahlpa, to la changea, impotence, f e r t i l i ty  
manatrual period*, a te ). Privacy and confidentially w ill be maintained.
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Doxorubicin (injection)
A commonly used brand neme it Adrlunycln RDF.______________
NATIONAL CANCER INSTITUTE
Office of Cancer Communications
Sa m M aktc
HEALTH SERVICES
About Your Medldno
DoxofwWelm (dox -tfhR O O -O M n) W o n g :  to  tlw  g o n m i  
g ro u p  c t  in o a c in w  know n u  o m in te p i iw iet  It S  givon by  
jn j ta io n  to  m a t  *onw  k M f  o f c artear.
H an y  of i m  M omnation in tN> laaflet eauM a you ip a d a l  cotv^ 
c am  o r  V you w ant ad d tio n a l M ctm aiian  abou t y o trm a d b in e  
and  It» usa, chack  with your doc to r, nuraa. o r p h a im a c * .
Before Using This Medicine 
D iseuaa  w ith y o u r d o c to r  tiM  p o aa ib lo  a id a  a tfa c ta  th a t m ay  
b a  c au a a d  by  th ia  m adicina. S o m a  of th am  m ay  b a  sarioua 
a n d /o r  tong-taim .
T a l your d o a o r .  nu rse , a n d  p h a rm ac is t I I y o u . . .
•  a re  aBargie to  a n y  m ad k in a . a ith a r proscription o r  n on - 
p rescrip tion  (OTCk
•  a r e  p reg n an t o r  in tend  to  h a v e  ehSdrsK
• a re  b raast-faad ing  a n  M a n e
• a re  taking a n y  o th e r p rescrip tion  o r  nonprascrlp tion  
(OTC) m e d ic in e
• h ave  a n y  o th e r  m edical p ro b lam s. especially  ch ickan  po x  
(including re c a n t axpoaura). h e a r t d ls a a s a .h a rp a a z o s -  
ta r  (shk iÿaa). M a c t io a  o r  Iv o r d is a a a c
« have  aver b e a n  tre a te d  w ith x -raya o r e ar tc arm atfe in a» .
Proper Use of This Medicine
Whila you a re  using  th is  m adicina. y o u r d o c to r  m ay  w an t you
to  drink ex tra  fluids s o  th a t y o u  WÜ p a s s  m o re  urine. This w S
haip  p reven t k idney p rob lam s a n d  k e e p  your kidnays w orking
wafl.
D oxorubicin o ften  c a u s e s  n a u se a  a n d  vom iting. How ever, it 
is  vary im portant th a t  yo u  con tin u a  to  racaiva  fl. e ven  if you  
begin  to  feat M. A sk  you r d o c to r, nu rse , o r  pharm acist (or 
w ays to  lessen  th e s e  affect»._______________________________
Precautions While Using This Medicine
It is  v a ry  im p o rtan t th a t  y o u r d o c to r  c h a c k  y o u r p ro g re s s  
a t  re g u la r  v isits  to  m ak e  su ra  th is  m adicina is working p ro p ­
erty a n d  to  c h ack  for u n w an ted  a ffec ts .
While you  a re  being  tre a te d  w ith doxorubicin , a n d  for savarat 
w eeks a fte r you  s to p  trea tm en t, d o  n o t h a v e  a n y  im m uni- 
z s tio n s  w ithout y o u r  d o c to r 's  a p p ro v s L  Doxorubicin low ers 
your re s is tan ce  a n d  th e re  is  a  c h a n c e  you  m ight g e t  th e  
infection th e  im m unization is m e a n t to  p revenL  O th e r p eo p le  
in your househo ld  shou ld  a lso  avo id  im m unizations s in ce  th ey  
could  p a s s  th e  M ec tlo n  o n  to  y o u . A lso, avoid  p eo p le  with 
co ld s  o r  o th e r infections,
•  F ast o r irregular 
h e a rtb ea t
• Fever, chins, o r  so re  
throat
•  D arkening o r  re d n e ss  
o f th e  sk in  (a fte r x-ray
•  J o M p a k
Side Effects of This Medicine
SMs EHSets n u t Should 0s Aeported To Tour Oeetor
lamudlêl»^
• R ed n ess, p a k .  o r sw eB ng a t 
th e  p la c e  of k ie c tio n
•  S h o rtn ess  of b rea th
•  S w eflkg  of feet a n d  low er legs
•  U nusual bleeding o r bruising
•  W heezing
&do Eltoeta V ut StuuU Bo Ropotlod As Soon As 
PossiUo
•  S id e  o r  s to m ach  p a k  
■ S k k  ra sh  o r itching
•  S o re s  k  th e  m outh  a n d  on  
th e f lp s
SUo B ^ets TIM UsusOy Do Not HootOro Modle  ^
Attontlon
T hese  possib le  s id e  e ffec ts  m a y  g o  aw ay  during trea tm en t: 
however, if th ey  con tinue  o r  e re  bo thersom e, ch ec k  w ith your 
doctor, nurse , o r  p h a rm a d sL  
•  Darkening of th e  so les . •  D iarrhea
palm s, o r nans •  N a u se a  an d  vomiting
O oxorub ick  c a u s e s  th e  u r k c  to  turn  reddish k  color, which 
m ay  s i a k  d o th e s .  T his is n o t b lo o d , ft is to  be  e x p e c te d  and  
ia s t t  for 1 o r 2  d a y s  a fte r e a c h  d o s e  is given.
This m edicine o h e n  c a u s e s  a  te m p o ra ry  a n d  to ta l lo ss  of hair. 
A her trea tm en t w ith d o x o ru b ic k  h a s  ended , norm al hair 
grow th shou ld  re turn .
O ther s id e  e ffec ts  n o t Ested a b o v e  m ay  a lso  o c cu r k  som e 
petien ts. If y o u  no tic e  e n y  o th e r  e ffects, c h eck  with your 
doc to r, nurse , o r p h a rm a d sL
A fter y o u  s to p  receiv ing  d o x o ru b ic in , it m ay  stifl p ro d u c e  
s o m e  s id e  e f fe c ts  t h a t  n e e d  a t t e n t io n  During th is period  of 
time, c h e c k  w ith  y o u r  d o c to r  im m ed ia te ly  if you no tic e  sho rt­
n e ss  of b rea th , swelling o f fe e t a n d  lower legs, o r  fa s t or 
k e g u ta r  h e a r tb e a t
Tlw bUMMllM k  IMS iMrtol » 
u s e  or tar MSS S t sn  aevcausnsl aW tiM S ss t a st ssv sr sa  ess- 
ttata  ssss . scttams. Qtscsstlsris. sM s sWssta. s r  tan rscris s s  sT
•  i n i  t v  UsssS S iua  Wuisiinnetiil Css-n sa a  lac Pi s i V r  IMt
S p e d a i  In s tru c tio n s:
F o r m o re  in fo rm a tio n  can  th e  
C a n c e r  In fo rm ation  S e rv ic e  to ll-free a t:
1-800-4 CANCER •/M-M
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Fluorouracil (injection)
Some commonly uwd brand nmmw or other nmm#* ere Admet! end 5-FU.
NATIONAL CANCER INSTITUTE
Office of Cancer Communications
About Your Medldne
n u e r o u r a e a  ( n u r » ^ Y 0 0 R 4 < * n )  M to n g s 'lo  ttw  g ro u p  of 
m odieinM  kncw tt u  in titM ia b o lii ts .  It k  g iv tn  by  bijoetion 
t o  Iroal ib m o  klnOt o f eoneo r.
If a n y  of iho  W ormailom ki t f *  laaBat c a u i a t  you tp a d a l  eon* 
c o m  o r l y o y  w ant addW onal IntormaUon abou t your maOWna 
a n d  Ba w e .  c b a d t with your docto r, r a m ,  o r p ha tm ack t.
Before Using This Medicine 
O lacu sa  w ith y o u r  d o c to r  th a  p o aa lb la  a id e  a ffaeta  th a t m ay  
b a  c a u a a d  b y  th k  m adicina. S o m a  o f th a m  m ay b a  aarioua 
a n d / o r  tong-tarm .
T a l  you r doc to r, nuraa . a n d  p h a rm a c k t If y o u . . .
•  a ra  a le rg ie  to  a n y  m adicina. a ithar proaeription o r non» 
praacription (OTC):
•  a ra  p regnan t o r In tend  to  h av e  children;
•  a ra  braaai» laeding  a n  infant;
•  a ra  tak ing  a n y  o th e r  p ra te rip iio n  o r nenpraacrip tien  
(OTC) m ad id n a ;
•  h av e  an y  o th e r  m ed ica l proM am a.aapaci8B y ch ickan  p ox  
(including re c an t axpoau ra). fw rpaa  zoatar (ahingias). 
inlaction. k idney d iaaaaa . o r W ar d k a aa a :
« h av e  aver b e a n  tre a te d  with x»raya o r  can ce r m adicinea.
Proper Use of This Medicine 
F tu o ro u rad l often  c au a a a  n au aea  a n d  vomiting. However. It 
k  vary .knportan i th a t  y ou  con tinua  to  receive the  m adicina. 
e v e n  If you begin to  faal 0 .  Aak y o u r d o c to r, nuraa. o r phar* 
m a c ia t lor w aya to  laaaan  ih e aa  a ltac ta .____________________
Precautions While Using This Medicine 
It k  v a ry  Im p o rtan t t h a t  y o u r d o c to r  c h e c k  your p ro g raaa  
a t  re g u la r  v k lta  to  m a k e  aura th k  m adicina k  working p ro p ­
e rly  a n d  to  c h ac k  for u n w a n ted  a lla c ts .
WhBa y ou  a re  being tre a te d  with h u o ro u ra c t  and  lor aaveral 
w e e k s  a lte r  you  s to p  tre a tm en t, d o  n o t  h av e  a n y  Im m uni­
z a t io n s  w ith o u t y o u r d o c to r 's  a p p r o v a l  FluorouracB towers 
y o u r raa ia tanca  a n d  th e re  k  a  c h a n c e  y ou  might g e t th a  
in fac tion  th a  Im m unization k  m ean t to  p ravem . O ther p a o p k  
In y o u r househo ld  s h o u ld  a lso  avo id  knm unizaiions s ince  they  
c o u ld  p a s s  th a  infection  on  to  you. A k o . avoid p a o p k  with 
c o ld s  o r o th e r ktlacU ons.
•  B lacir ta rry  a to o k
•  O ia n h aa
•  F ever. eh B s. o r  so re  
th ro a t
•  H eartb u rn
Sid# Effects of This Modicin#
su »  B M c ts  T h a r S h o u ld  S e  tt»pon»a To Your Doctor
ImmtSlotoiy
• N au sea  a n d  vom iting 
(severe)
« S o re s  ki th e  m o u th  a n d  on  
th e  Ups 
« S to m a c h  c ra m p s  
« U nusual b leed ing  o r bruising
s w a  S ffiee tt n a r  SnoulS S e  m ap o m ad  A t Soon A t 
P ettlbh
• C h e s t  p a k i •  OMIculty w ith b a k n c a
,  C o u g h  • S h o rtn ess  o f b re a th
SUo Elftets T h a t Ututlly Do Not Ntqulrt W ad lea l 
AnontlOa
T h e s e  p o a s ib k  s id e  a t le c ts  m ay  g o  aw ay  during  tre a tm en t; 
how ever. If th e y  c o n tin u a  o r a re  bo th e rso m e , c h e c k  w ith your 
d o c to r, n u rse , o r  p h a rm a c k t.
« L o ss  o f a p p e t ite  •  Skin ra sh  a n d  Itching
•  N a u se a  a n d  vom iting < W eakness  
(m ad)
T h k  m e tS d n e  g h e n  c a u s e s  a  lem pora ry  lo ss  of hair. A her 
tre a tm e n t w ith Ituo rou racI h as  e n d ed , norm al h a k  g row th  
sh o u ld  re tu rn .
O th e r s id e  e ffe c ts  n o t fisted  above  m ey  a k o  o c cu r  In so m e  
p e tk n ts .  If y ou  n o tice  a n y  o ther effec ts, c h ec k  w ith your 
d o c to r, n u rse , o r p h a r m a e k l
A fte r y o u  s to p  rec e iv in g  fluorouracil. It m a y  stlfi p r o d u c e - 
s o m e  s id e  e lf e c ts  th a t  n e e d  a tte n tio n . O unng th k  period  of 
tim e, c h a c k  w ith  y o u r d o c to r  Im m ed ia te ly  U y o u  n o tic e  lever, 
ch fik . o r s o re  th ro a t o r  unusual b k e d in g  o r bruking.-
•  t n i  The IMmS S u u i
S p e c ia l  In s tru c tio n s ;
F o r m o re  m io rm atlon  can  th a  
C a n c e r  In fo rm atio n  S e rv ice  to n -fre e  a t:
1-800-4 CANCER
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APPENDIX c
Fatigue Pamphlet—Nursing Intervention
Fatigue
u
a
I
PL.
Whatltls&
What to do about It
Sam Marys
H E A L T H  S E R V I C E S
♦  WHAT IS FATIGUE?
Fatigue is when a person feels tired sooner 
than usual after a physical, mental or emotional 
activity. It can make you feel as if you have lost 
energy. You may find that you ate not able to do as 
much during the day as usual Many people describe 
fatigue as feeling tired or weak. Most of the lime it 
goes away with rest or sleep. Fatigue can range from 
feeling "pretty good* to feeling like y ou are "ready to 
drop." People have called it being "worn out," 
"weary," "listless." or "pooped" or having "no en­
ergy." Fatigue can affect bow much energy you have 
for life's daily tasks, and it can affect bow well you 
do those tasks.
♦  HOW DO YOU KNOW YOU ARE 
FATIGUED?
Not everyone feels the tame way when she 
or be is fatigued; however, there are some oommon 
ways people lookoractwhea they fret tired. Fatigue 
can affect a person's outlook by changing Us or her 
drive or inlerest in life. SometiniesafÛigued person 
may feel like crying, or he or she may want to sleep 
more oflcn. Talking more slowly is common, and a 
fatigued personmay give short answers toqueslions 
because he or she Just may not feel like talking. 
Fatigue may cause someone to look pale or shaky: 
she or he may not smile as often. Psyüg attention to 
concentrating may also be difUcuk. Normal tasks 
such as housework or yard work could be difficult to 
start or finish. People mtgr have all or none of these 
common signs of btigue; they are dmply things to 
watch for.
♦  WHO FEELS FATIGUE?
Most people with cancer will be fatigued at 
some tirtte during their illness. Radiation, chemo­
therapy, surgery, and treatment with biological re­
sponse modifiers have been shown to cause fatigue. 
Fatigue is also a oommon problem for other types of 
patients: those with kidney or heart disease, food 
poisoning, chronic fatigue syndrome, or long-term 
illnesses, as well as those having surgery.
♦  WHAT CAUSES FATIGUE?
Fatigue can be caused by physical prob­
lems, mental stress, or difficulties in a person's daily 
life. Physical problems that might cause fatigue are 
tumors, stress, medications, anemia, or a hormone 
fanbalance.Tumort can cause fatigue by competing 
with the body for nutrients. A person whobas nausea 
or is vomiting may not take in the food needed to 
keep up Ids or her energy. Surgery, infections, or 
fever cause the body to need more energy. Without 
enough energy, a person will feel fatigued. Some 
patients find that it lakes a long lime for tbeir energy 
lo return after treatment; however, most find that it 
returns quickiy once treatment is finished.
How someone thinks or feels can affect 
fatigue as weii. Some patients feel fatigue as a 
symptom of anxiety or depression. Feelings of grief 
or loss can also make a penoo feel tired or listless.
Emotiorul stress in a patient's daily life 
may increase feelings of fatigue. Conflict, worry, 
MNbess, or tensions among family members or oth­
ers will require energy to work miL Times of crisis, 
such as recurrence of cancer, are hard lo cope with 
for both patients and their families. More energy is 
needed lo handle these crises.
Changes in daily schedules or routines can 
cause fatigue. In a hôpital many tests can be given, 
sometimes within a short time spatL Sleep routines 
may be different at night; this can often cause feel­
ings of being worn ouL Many patients with cancer 
need to change their routine with respect to how they 
get Grom one place to another. Don't forget that if y DU 
need a walker or crutches to move, you will use extra 
energy.
♦  HOW CAN I CONTROL MY FATIGUE?
Knowing what is causing your fatigue will 
help you decide bow to make it less severe. Think 
very hardabout what activities tire you themosLTry 
making a list with two colurrms. Write the things that 
must be done today hr the first oolunm and the things 
that can wait until tomorrow in the second column. 
Then rank activities by listing them far order from
CO
VO
'd01I4Jaoo
most important lo least important Use Ihis list to 
make a plan thaï you can sikk l% starting with the 
most important activities; try to use the suggestioas 
listed bdow. Many of than are based on the idea of 
using less energy so that yon can save what energy 
you do have for the most important activités. Ibis 
idea oouM be thought of as putting energy "into the 
bank” lo later "wilhdmv* when you need it  Keep in 
mind that setting easy goals that you can really 
achieve may help to lessen your feelings of fatigue. 
Most of these ideas have come Grom other patients 
with cancer who have used them lo cope with thdr 
fatigue.
♦  SPECIFIC SUGGESTIONS
f  SSorll#dotim om #n. Short periods 
ofrest are better than long ones. Tbis is because the 
heart rale slows down very quickly at the beghmhtg 
of a rest period, but more slowly at the end of a rest 
period. Msrry short rests, then, give the heart more 
chances to beat skNver and ttus tire less.
fTmka nap#. Napscanbehelpliilaa long 
as lhay don't cause you to have problems falling 
asleep at ulghL
4  Plan aethrMos. Limit theenergy used 
on plantdng activities. Do the irrqnrtant activités 
firsL and decrease the number of less important 
activities. Most people have more energy for the 
ddngsthaldiey enjoy andfedbestwhendoing them. 
Let others help you by Idling them what they can do 
for you. Iky to keep your daily life simple.
4  Raarl. Many people find that readng 
helps them keep their mind off faigue.
4WalMmtarelaa.R%ulsr,lighte%ercise 
such as rvaUdng has been shotvn to decrease Cstigue^  
as well as nausea and vomiting, in some patients.
4 U aa  iilailnctlon.Peopteuseniatqr rou­
tines tokeep their rtrind off how dted they are. Ibese 
routines might include: going to work, taking car 
tides, Hneoirrg to toft music or relaxation tapes, 
doing yoga, or anything dse that bdps you to relax 
afterahardday.Abopefuloutlookontheproblemof 
fatigue will also help.
4  Sleep. Start or follow anormal sleqiing
rou tine .
4  Eat a  Iwlanced d ie t Eating the right 
foodstogiveyouenergyisimponanLTbeNatiaod 
Cancer Institute publithiesa&ee booklet called Eof- 
ihg Mr, which may be helpAiL You may ask your 
nuiseordoclorfortl^bookleLYoumaydtoaskfor 
aieferraltoadielitian,whoaliocan give you helpful 
ideas.
4  Make aurn you'ia oomfoitabla.
When you are too cold or too hot you mqr tire more 
qdckly. Avoid temperalutesgrealerthan75degrees 
F and humidily gtrêler lhan 60%.
4  Maintain your aed a l Me. To lessen 
fatigue^  many peoplelimil their todal life and other 
fuoactivltieslirsLTkytokeepahdanoe between the
■ rtiv tltM yniin iw rA iM iitltinM ittm m atrnynM tifjy
far ddly life.
4  Talk to  your iloctor o r  nuraa 
practtUonar.Somepalicaisliavegotienrelieffrom 
fatlgueby taking medications, soask your doctor or 
nurse practitiorreriftheseorothernrethods might be 
used to treat your fatigue.
4 CONCLUSION
For many people, fatigue can be a hard 
proUemtomarutgeL What wotfcs for onepcrsonmgy 
not work for another. Finding out what works best 
takestimrandeffort,toke^tryingtofindoutwhicfa 
methods rvork best for yon. The American Cancer 
Society and the Nstiond Cancer hrstitule can pro­
vide you with more Information about variouskhids 
of cancer and cancer treatments, as well as the side 
eftecu of these treatments.
o>
VO
CnaUdbyKanHA,SkaUaACher^Laeastt
APPENDIX D
Piper Fatigue Scale—Baseline
APPENDIX D
For each o f  the following questions, c i r c le  the number which bes t describes 
the fa tigue  you a re  experiencing now.
1. To what degree are  you experiencing fa tigue now? (23-24)
No fa tigue  A g rea t  deal o f  fa tigue
0 1  2 3 4 5 6 7 8 9  10
2. How severe I s  the  fa t ig u e  which you are  experiencing now? (25-26)
No fa tigue  Worst f a t ig u e  ever experienced
0 1 2 3 4 5 6 7 8 9  10
3. How long have you been fee ling  fatigued? (check one response only) (27)
A.
8.
C.
D.
E.
F.
minutes
hours
days
weeks
months
Other (Please describe)
4. How would you describe  the fa tigue  which you are f e e l in g  now?
A. In te rm it te n t
0 1 2 3 4 5 6
8. Acute
0 1 2 3 4 5 6
C. Localized
(To a s p e c i f ic  muscle group/extremity)
0 1 2 3 4 5 6
Continuous (28-29)
8 9 10
Chronic (30-31)
8 9 10
Generalized (32-33) 
(Whole body Is fatigued)
8 10
Adapted from Piper 1992.
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5. To what degree has your fa t ig u e  changed in the past week? (34-35)
Decreased Increased
0 1  2 3 4 5 6 7 8 9  10
6. To what degree I s  the  fa t ig u e  you are  fe e l in g  causing you d is tre ss? (36 -37 )
No d is t r e s s  A g rea t  deal o f  d is t r e s s
0 1  2 3 4 5 6 7 8 9  10
7. To what degree I s  the  fa t ig u e  you are fe e l in g  in te r fe r in g  with your 
a b i l i t y  to  c lean your house/home? (38-39)
None A g rea t  deal
0 1  2 3 4 5 6 7 8 9  10
8. To what degree i s  the  fa t ig u e  you are fe e l in g  in te r fe r in g  with your 
a b i l i t y  to  cook f o r  you rse lf?  (40-41)
None A g rea t  deal
0 1  2 3 4 5 6 7 8 9  10
9. To what degree i s  the fa t ig u e  you are fee l in g  in te r fe r in g  with your 
a b i l i ty  to  bathe o r  wash yourself?  (42-43)
None A g re a t  deal
0 1  2 3 4 5 6 7 8 9  10
10. To what degree i s  the fa t ig u e  you are fee l in g  in te r fe r in g  with your 
a b i l i t y  to  read? (44-45)
None A g rea t  deal
0 1  2 3 4 5 6  7 8 9  10
11. To what degree i s . t h e  fa t ig u e  you are fee l in g  in te r fe r in g  with your 
a b i l i t y  to  dress  you rse lf?  (46-47)
None A g rea t  deal
0 1  2 3 4 5 6 7 8 9  10
12. To what degree i s  the fa t ig u e  you are fee l in g  in te r fe r in g  with your 
a b i l i t y  to  complete your work or school a c t iv i t i e s ?  (48-49)
None A g rea t  deal
0 1  2 3 4 5 6 7 8 9  10
13. To what degree i s  the fa t ig u e  you are fee l in g  in te r fe r in g  with your
a b i l i t y  to  v i s i t  o r  s o c ia l iz e  with your fr iends?  (50-51)
None A g re a t  deal
0 1  2 3 4 5 6 7 8 9  10
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14. To what degree Is  the  fa tigue  you are fee l ing  in te r f e r in g  with your 
a b i l i t y  to  engage in  sexual ac t iv i ty ?  (53-54)
None
1 8
A grea t deal 
9 10
15. O verall ,  how much i s  the fa tigue  which you are experiencing now
in te r fe r in g  with your a b i l i t y  to  engage in  the kind o f  a c t i v i t i e s  you 
enjoy doing? (55-55)
None
1 8
A grea t deal 
9 10
16. How would you describe  the degree of in te n s i ty  or s e v e r i ty  o f  the fa tigue 
which you are experiencing now? (57-58)
Mild
1 8 10
Severe
17. To what degree would you describe the fa tigue  which you are  experiencing 
now as being:
A. Pleasant
0 1
B. Agreeable
0 1
C. P ro tective  
■ .6 • . 1
0 . ' P os itive  
0 1 
E. Normal 
0 1
Unpleasant (59-60) 
8 9 10
Disagreeable (61-62) 
8 9 10
D estructive  (63-64)
8 9 10
Negative (65-66)
8 9 10
Abnormal (67-68)
8 9 10
7 2
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People feeling  fa tigued  may experience ce r ta in  fee l in g s /sen sa t io n s  which 
indicate  to  them th a t  they are  fa tigued .  For each o f  the following ques tions,  
c i rc le  a number th a t  b e s t  ind ica tes  the degree to  which each fee l in g /sen sa t io n  
is  being experienced by you now.
18. To what degree are  you now fee l in g ;  (69-70)
Refreshed
0 1 2 3 4 5 6
19. To what degree are  you now fee l in g :  (71-72)
Strong
0 1 2 3 4 5 6
20. To what degree are  you now fee l in g :  (3-4)
Awake
0 1 2 3 4 5 6
21. To what degree are  you now fee l in g :  (5-6)
Lively
0 1 2 3 4 5 6
22. To what degree are  you now fee l in g :  (7-8)
A lert
0 1 2 3 4 5 6
23. To what degree are  you now fee l in g :  (9-10)
Refreshed.
0 1 2 3 4 5 6
24. To what degree are  you now feeling? (11-12)
Energetic
0 1 2 3 4 5 6
25. To what degree are  you now fee l in g :  (13-14)
Vigorous
0 1 2 3 4 5 6
26. To what degree are  you now fee l in g :  (15-16)
In te res ted
0 1 2 3 4 5 6
27. To what degree are  you now fee l in g :  (17-18)
Calm
0 1 2 3 4 5 6
Exhausted 
) 10
Weak
10
Sleepy
10
L is t le s s
10
Drowsy
10
Tired
10
Unenergetic 
9 10
Sluggish 
9 10
Bored
10
Nervous 
9 10
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28. To what degree a re  you now fe e l in g :  (19-20) 
Patient
0 1 2 3 4 5 6
29. To what degree a re  you now fee l in g :  (21-22)
Motivated
0 1 2 3 4 5 6
30. To what degree a re  you now fee l in g :  (23-24)
Happy
0 1 2 3 4 5 6 7
31. To what degree a re  you now fee l in g :  (25-26)
Relaxed
0 1 2 3 4 5 6 7
32. To what degree are  you now fee l in g :  (28-29)
Exhilarated
0 1 2 3 4 5 6 7
33. To what degree are  you now fee l in g :  (30-31)
Able to  concentrate
0 1 2 3 4 5 6 7
34. To what degree are  you now fee l in g :  (32-33)
. Able to  remember
0 1  2 -  3 4 5 6 7
35. To what degree are  you now fee l in g :  (34-35)
Able to  th ink  c l e a r ly
0 1 2 3 4 5 6 7
Im patient 
9 10
Unmotivated 
9 10
10
10
Sad
Tense
Depressed
10
Unable to  concentrate  
9 10
Unable to  remember 
9 • 10
Unable to  th ink c le a r ly  
8 9 10
36. Overall, what do you believe Is most d i r e c t ly  con tribu ting  to  or causing 
the fa tigue  you a re  now experiencing? (36-37)
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37. Overall, when you experienced fa tigue  today, the  bes t  th ing you found 
which relieved your f a t ig u e  was: (38-39)
38. Is  there anything e lse  you would like to  add t h a t  would describe your 
fa tigue  b e t te r  to  us? (40-41)
39. Are you experiencing any o th e r  symptoms r ig h t  now?
No _____
Yes _____  (42) Please d e s c r i b e ______________________________________  (43)
27.75N
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This survey is divided into 2 sections. The first is the infijrmation section that asks 
you some basic questions about yourselT your diagnosis, and your treatment. The second 
section is the main part o f this survey. Please follow the directions provided and answer 
all of the questions to the best o f your ability. Thank you for your time.
SECTION 1— Information
I. Age: ___________________  2. Sex: M  F___
3. Type of cancer:________________________________________________________
4. Chemotherapy regimen (name of chemotherapy drugs you are receiving):___________
(if you are unsure, please ask a nurse to fill in this information for you)
5. Previous history of cancer? Y e s  No
If yes, were you treated with (circle all that apply):
a. chemotherapy b. radiation c. surgery
6. Where do you live? in a house in an apartment  in a nursing home
other (please specify)_______________________________________________________
7. How many people live with you?  (please include all adults and children)
8. Of those living with you, how many can you rely on for some type of support?______
(for example, help you with housekeeping, meals, errands, etc.)
9. Do you have any type of home care? Meals on wheels  Nursing services_____
Hospice  Oxygen  Other_________________________________________
10. Do you have any other medical condition? If so, please specify
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Information and Informed Consent for Research Project Participation
The study in which you are being asked to participate is titled “Assessment of 
chemotherapy-induced side effects.” The purpose of this study is to evaluate the 
effectiveness of nursing techniques used to help patients with side effects brought on by 
chemotherapy treatments. As a participant you will be asked to give permission to the 
researcher to gather and use data from your records which include age, sex, primary and 
secondary diagnoses and type of chemotherapy treatment. You will also be asked to fill 
out two scales. The first one will be filled out today and takes approximately 15 minutes. 
The second scale will be filled out on the first day of your third treatment. This form also 
takes approximately 15 minutes.
Every attempt will be made to maintain your confidentiality. Each form will be 
numerically coded so that only the researcher can identify which subject filled out which 
forms. After all data are collected the list o f names and numbers will be destroyed. Your 
name will never appear on the research materials. All final reports and papers will never 
discuss individual findings and will include only group data.
Risks associated with participation in the study include confidentiality issues (see 
previous paragraph), time loss (time involved in entire study should not exceed 1 hour) 
and additional stress by having to participate in a study on your first day of chemotherapy 
treatment. Every attempt will be made to facilitate and expedite the research process.
The researcher or an RN will be available to answer any questions you may have. You
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also retain the right to withdraw from the study at any time without any change in the 
services or care provided to you at the clinic. While there are limited personal risks 
associated with participation in the study, there are also limited personal benefits. The 
indirect benefit of the project is its impact on nursing practice provided to you and other 
patients undergoing similar treatment.
This study is being conducted by Jennifer Shane, RN, and is a partial fulfillment of 
requirements for the master’s degree program at Grand Valley State University. It is 
understood that the researcher is in charge o f this study and with your welfare as a basis, 
may decide at any time that you should no longer participate in the study. If you choose, 
you may also withdraw from the study at any time. If you have any questions about the 
study, please feel free to contact Mrs. Shane at 36I-0946-H or 774-6218-W.
I have read and understand the above infonnation and have been given the 
opportunity to question and clarify the information reviewed. I consent to participate in 
the research study described. I also authorize the researcher to include the information in 
reports or nursing literature while maintaining confidentiality. A summary of the results 
will be made available to me upon my request.
Participant date Witness date
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APPENDIX G
Outline of Nursing Inservice
I. Introduction to research project 
n. Background infonnation
a. Literature review
b. Conceptual framework 
m . Research question and hypothesis
IV. Procedure o f study
V. Criteria for patient eligibility
VI. How to offer participation and obtain consent
a. Script
b. Case scenarios 
vn. Interventions
a. Control vs Experimental group 
v m . Questions and Answers
79
APPENDIX H
Script for Offering Participation
APPENDIX H
Script for Offering Participation
One of our former chemotherapy nurses is working on her thesis. She is trying to 
impact cancer patients’ quality of life by exploring more about what nurses can do to 
alleviate side effects associated with chemotherapy. We are assisting her with this project. 
All you need to do is read and sign the consent form (which explains more about the 
study) and then fill out a questionnaire today and again when you come in for your third 
cycle of chemotherapy. The form only takes 10-15 minutes to fill out and you can do it 
while you wait. By all means, if you do not care to participate, that’s OK. It will not 
affect the care you receive here at all. If you have any questions today ask me otherwise 
the consent form lists the researchers’ phone number. Would you care to read the consent 
form?
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